Annual Statements Open main menu

REINSURANCE GROUP OF AMERICA INC - Quarter Report: 2019 March (Form 10-Q)

Table of Contents


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
 
 
 
 
 
(Mark One)
  
 
  
 
 x
  
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
  
 
  
OF THE SECURITIES EXCHANGE ACT OF 1934
  
 
 
  
For the quarterly period ended March 31, 2019
  
 
 
  
 
OR
 
  
 
 ¨
  
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
  
 
  
OF THE SECURITIES EXCHANGE ACT OF 1934
  
 
 
  
 
Commission File Number 1-11848
  
 
REINSURANCE GROUP OF AMERICA, INCORPORATED
(Exact name of Registrant as specified in its charter)
MISSOURI                        
  
43-1627032
(State or other jurisdiction                  
  
(IRS employer
of incorporation or organization)  
  
identification number)
16600 Swingley Ridge Road
Chesterfield, Missouri 63017
(Address of principal executive offices)
(636) 736-7000
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x  No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes x  No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer x     Accelerated filer o     Non-accelerated filer o     
Smaller reporting company o     Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o  No x


Table of Contents


Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Stock, par value $0.01
 
RGA
 
New York Stock Exchange
6.20% Fixed-To-Floating Rate Subordinated Debentures due 2042
 
RZA
 
New York Stock Exchange
5.75% Fixed-To-Floating Rate Subordinated Debentures due 2056
 
RZB
 
New York Stock Exchange
As of April 30, 2019, 62,560,064 shares of the registrant’s common stock were outstanding.


Table of Contents


REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
TABLE OF CONTENTS
 
Item
  
 
  
Page
 
 
 
 
  
PART I – FINANCIAL INFORMATION
  
 
 
 
 
1
  
  
 
 
  
  
 
  
  
 
  
  
 
 
 
 
  
  
 
  
  
 
 
 
 
 
 
 
 
     3. Equity
 
 
 
     4. Investments
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     9. Income Tax
 
 
 
 
 
 
     11. Reinsurance
 
 
 
 
 
 
 
2
  
  
3
  
  
4
  
  
 
 
 
 
  
PART II – OTHER INFORMATION
  
 
 
 
 
1
  
  
1A
  
  
2
  
  
6
  
  
 
  
  
 
  
  

2

Table of Contents


PART I - FINANCIAL INFORMATION


REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
(Unaudited)
 
 
March 31,
2019
 
December 31,
2018
 
Assets
 
 
 
 
Fixed maturity securities available-for-sale, at fair value (amortized cost $39,188,627 and $38,882,168)
 
$
41,738,443

 
$
39,992,346

Equity securities, at fair value (cost $111,785 and $107,721)
 
89,865

 
82,197

Mortgage loans on real estate (net of allowances of $11,218 and $11,286)
 
5,117,545

 
4,966,298

Policy loans
 
1,312,349

 
1,344,980

Funds withheld at interest
 
5,729,838

 
5,761,471

Short-term investments
 
119,215

 
142,598

Other invested assets
 
2,006,870

 
1,915,297

Total investments
 
56,114,125

 
54,205,187

Cash and cash equivalents
 
2,020,396

 
1,889,733

Accrued investment income
 
442,956

 
427,893

Premiums receivable and other reinsurance balances
 
2,857,673

 
3,017,868

Reinsurance ceded receivables
 
814,806

 
757,572

Deferred policy acquisition costs
 
3,404,593

 
3,397,770

Other assets
 
1,037,932

 
839,222

Total assets
 
$
66,692,481

 
$
64,535,245

Liabilities and Stockholders’ Equity
 
 
 
 
Future policy benefits
 
$
25,976,847

 
$
25,285,400

Interest-sensitive contract liabilities
 
17,750,197

 
18,004,526

Other policy claims and benefits
 
5,911,554

 
5,642,755

Other reinsurance balances
 
517,096

 
487,177

Deferred income taxes
 
2,144,680

 
1,798,800

Other liabilities
 
1,278,108

 
1,396,200

Long-term debt
 
2,787,717

 
2,787,873

Collateral finance and securitization notes
 
656,174

 
681,961

Total liabilities
 
57,022,373

 
56,084,692

Commitments and contingent liabilities (See Note 8)
 


 


Stockholders’ Equity:
 
 
 
 
Preferred stock - par value $.01 per share, 10,000,000 shares authorized, no shares issued or outstanding
 

 

Common stock - par value $.01 per share, 140,000,000 shares authorized, 79,137,758 shares issued at March 31, 2019 and December 31, 2018
 
791

 
791

Additional paid-in-capital
 
1,906,291

 
1,898,652

Retained earnings
 
7,412,081

 
7,284,949

Treasury stock, at cost - 16,593,411 and 16,323,390 shares
 
(1,415,020
)
 
(1,370,602
)
Accumulated other comprehensive income
 
1,765,965

 
636,763

Total stockholders’ equity
 
9,670,108

 
8,450,553

Total liabilities and stockholders’ equity
 
$
66,692,481

 
$
64,535,245

See accompanying notes to condensed consolidated financial statements (unaudited).

3

Table of Contents


REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share amounts)
(Unaudited)
 
 
 
Three months ended March 31,
 
 
2019
 
2018
Revenues:
 
 
Net premiums
 
$
2,737,813

 
$
2,582,551

Investment income, net of related expenses
 
579,877

 
516,329

Investment related gains (losses), net:
 
 
 
 
Other-than-temporary impairments on fixed maturity securities
 
(9,453
)
 

Other investment related gains (losses), net
 
17,241

 
(470
)
Total investment related gains (losses), net
 
7,788

 
(470
)
Other revenues
 
94,553

 
75,297

Total revenues
 
3,420,031

 
3,173,707

Benefits and Expenses:
 
 
 
 
Claims and other policy benefits
 
2,508,324

 
2,362,101

Interest credited
 
133,189

 
80,449

Policy acquisition costs and other insurance expenses
 
311,881

 
356,902

Other operating expenses
 
201,483

 
191,274

Interest expense
 
40,173

 
37,454

Collateral finance and securitization expense
 
8,417

 
7,602

Total benefits and expenses
 
3,203,467

 
3,035,782

 Income before income taxes
 
216,564

 
137,925

Provision for income taxes
 
47,057

 
37,695

Net income
 
$
169,507

 
$
100,230

Earnings per share:
 
 
 
 
Basic earnings per share
 
$
2.70

 
$
1.55

Diluted earnings per share
 
$
2.65

 
$
1.52

See accompanying notes to condensed consolidated financial statements (unaudited).

4

Table of Contents


REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands)
(Unaudited)
 
 
 
Three months ended March 31,
 
 
2019
 
2018
Comprehensive income (loss)
 
 
Net income
 
$
169,507

 
$
100,230

Other comprehensive income (loss), net of tax:
 
 
 
 
Foreign currency translation adjustments
 
21,386

 
(1,160
)
Net unrealized investment gains (losses)
 
1,108,211

 
(633,604
)
Defined benefit pension and postretirement plan adjustments
 
(395
)
 
(471
)
Total other comprehensive income (loss), net of tax
 
1,129,202

 
(635,235
)
Total comprehensive income (loss)
 
$
1,298,709

 
$
(535,005
)
See accompanying notes to condensed consolidated financial statements (unaudited).

5

Table of Contents


REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands except per share amounts)
(Unaudited)
 

 
Common
Stock
 
Additional Paid In Capital
 
Retained
Earnings
 
Treasury
Stock
 
Accumulated Other Comprehensive Income
 
Total
Balance, December 31, 2018
$
791

 
$
1,898,652

 
$
7,284,949

 
$
(1,370,602
)
 
$
636,763

 
$
8,450,553

Adoption of new accounting standards
 
 
 
 
(87
)
 
 
 
 
 
(87
)
Net income
 
 
 
 
169,507

 
 
 
 
 
169,507

Total other comprehensive income (loss)
 
 
 
 
 
 
 
 
1,129,202

 
1,129,202

Dividends to stockholders, $0.60 per share
 
 
 
 
(37,707
)
 
 
 
 
 
(37,707
)
Purchase of treasury stock
 
 
 
 
 
 
(49,052
)
 
 
 
(49,052
)
Reissuance of treasury stock
 
 
7,639

 
(4,581
)
 
4,634

 
 
 
7,692

Balance, March 31, 2019
$
791

 
$
1,906,291

 
$
7,412,081

 
$
(1,415,020
)
 
$
1,765,965

 
$
9,670,108


 
Common
Stock
 
Additional Paid In Capital
 
Retained
Earnings
 
Treasury
Stock
 
Accumulated Other Comprehensive Income
 
Total
Balance, December 31, 2017
$
791

 
$
1,870,906

 
$
6,736,265

 
$
(1,102,058
)
 
$
2,063,631

 
$
9,569,535

Adoption of new accounting standards
 
 
 
 
(2,020
)
 
 
 
 
 
(2,020
)
Net income
 
 
 
 
100,230

 
 
 
 
 
100,230

Total other comprehensive income (loss)
 
 
 
 
 
 
 
 
(635,235
)
 
(635,235
)
Dividends to stockholders, $0.50 per share
 
 
 
 
(32,241
)
 
 
 
 
 
(32,241
)
Purchase of treasury stock
 
 
 
 
 
 
(2,616
)
 
 
 
(2,616
)
Reissuance of treasury stock
 
 
9,446

 
(4,689
)
 
5,851

 
 
 
10,608

Balance, March 31, 2018
$
791

 
$
1,880,352

 
$
6,797,545

 
$
(1,098,823
)
 
$
1,428,396

 
$
9,008,261


See accompanying notes to condensed consolidated financial statements (unaudited).



6

Table of Contents


REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)
 
 
Three months ended March 31,
 
 
2019
 
2018
 
 
 
Cash Flows from Operating Activities:
 
 
 
 
Net income
 
$
169,507

 
$
100,230

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
Change in operating assets and liabilities:
 
 
 
 
Accrued investment income
 
(10,688
)
 
(10,484
)
Premiums receivable and other reinsurance balances
 
163,965

 
(275,354
)
Deferred policy acquisition costs
 
(17,784
)
 
13,007

Reinsurance ceded receivable balances
 
(65,053
)
 
(21,872
)
Future policy benefits, other policy claims and benefits, and other reinsurance balances
 
119,620

 
466,983

Deferred income taxes
 
39,490

 
33,715

Other assets and other liabilities, net
 
(107,266
)
 
(41,385
)
Amortization of net investment premiums, discounts and other
 
(16,659
)
 
(31,032
)
Depreciation and amortization expense
 
11,017

 
10,294

Investment related (gains) losses, net
 
(7,788
)
 
470

Other, net
 
62,260

 
(20,823
)
Net cash provided by operating activities
 
340,621

 
223,749

Cash Flows from Investing Activities:
 
 
 
 
Sales of fixed maturity securities available-for-sale
 
3,139,794

 
1,898,722

Maturities of fixed maturity securities available-for-sale
 
195,625

 
195,549

Sales of equity securities
 
83

 
29,683

Principal payments on mortgage loans on real estate
 
93,393

 
102,002

Principal payments on policy loans
 
33,271

 
10,694

Purchases of fixed maturity securities available-for-sale
 
(3,010,397
)
 
(1,969,899
)
Purchases of equity securities
 
(3,173
)
 
(2,173
)
Cash invested in mortgage loans on real estate
 
(240,411
)
 
(141,131
)
Cash invested in funds withheld at interest, net
 
(36,995
)
 
19,638

Purchase of businesses, net of cash acquired of $27,374 and $1,733
 
3,561

 
(24,864
)
Purchases of property and equipment
 
(10,440
)
 
(5,292
)
Change in short-term investments
 
25,422

 
(13,026
)
Change in other invested assets
 
(97,012
)
 
(23,353
)
Net cash provided by investing activities
 
92,721

 
76,550

Cash Flows from Financing Activities:
 
 
 
 
Dividends to stockholders
 
(37,707
)
 
(32,241
)
Repayment of collateral finance and securitization notes
 
(29,064
)
 
(27,104
)
Principal payments of long-term debt
 
(690
)
 
(662
)
Purchases of treasury stock
 
(49,052
)
 
(2,616
)
Exercise of stock options, net
 
1,755

 
1,163

Change in cash collateral for derivative positions and other arrangements
 
(44,628
)
 
19,537

Deposits on universal life and other investment type policies and contracts
 
44,926

 
83,004

Withdrawals on universal life and other investment type policies and contracts
 
(195,360
)
 
(156,486
)
Net cash used in financing activities
 
(309,820
)
 
(115,405
)
Effect of exchange rate changes on cash
 
7,141

 
21,989

Change in cash and cash equivalents
 
130,663

 
206,883

Cash and cash equivalents, beginning of period
 
1,889,733

 
1,303,524

Cash and cash equivalents, end of period
 
$
2,020,396

 
$
1,510,407

Supplemental disclosures of cash flow information:
 
 
 
 
Interest paid
 
$
40,193

 
$
39,284

Income taxes paid, net of refunds
 
$
3,076

 
$
6,356

Non-cash investing activities:
 
 
 
 
Transfer of invested assets
 
$
720,983

 
$
605,085

Right-of-use assets acquired through operating leases
 
$
1,311

 
$

Purchase of businesses:
 
 
 
 
Assets acquired, excluding cash acquired
 
$
8,303

 
$
59,184

Liabilities assumed
 
(11,864
)
 
(34,320
)
Net cash (received) paid on purchase
 
$
(3,561
)
 
$
24,864

See accompanying notes to condensed consolidated financial statements (unaudited).

7

Table of Contents


REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 
1.
Business and Basis of Presentation
Business
Reinsurance Group of America, Incorporated (“RGA”) is an insurance holding company that was formed on December 31, 1992. RGA and its subsidiaries (collectively, the “Company”) is engaged in providing traditional reinsurance, which includes individual and group life and health, disability, and critical illness reinsurance. The Company also provides financial solutions, which includes longevity reinsurance, financial reinsurance, asset-intensive products, primarily annuities and stable value products.
Basis of Presentation
The unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Accordingly, these condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements and should be read in conjunction with the Company’s 2018 Annual Report on Form 10-K filed with the SEC on February 27, 2019 (the “2018 Annual Report”).
In the opinion of management, all adjustments, including normal recurring adjustments necessary for a fair presentation have been included. Interim results are not necessarily indicative of the results that may be expected for the year ending December 31, 2019.
Consolidation
These unaudited condensed consolidated financial statements include the accounts of RGA and its subsidiaries and all intercompany accounts and transactions have been eliminated. Entities in which the Company has significant influence over the operating and financing decisions but are not required to be consolidated are reported under the equity method of accounting.
2.
Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share on net income (in thousands, except per share information):
 
Three months ended March 31,
 
2019
 
2018
Earnings:
 
 
 
Net income (numerator for basic and diluted calculations)
$
169,507

 
$
100,230

Shares:
 
 
 
Weighted average outstanding shares (denominator for basic calculation)
62,758

 
64,490

Equivalent shares from outstanding stock options
1,269

 
1,382

Denominator for diluted calculation
64,027

 
65,872

Earnings per share:
 
 
 
Basic
$
2.70

 
$
1.55

Diluted
$
2.65

 
$
1.52

The calculation of common equivalent shares does not include the impact of options having a strike or conversion price that exceeds the average stock price for the earnings period, as the result would be antidilutive. The calculation of common equivalent shares also excludes the impact of outstanding performance contingent shares, as the conditions necessary for their issuance have not been satisfied as of the end of the reporting period. The following table presents approximate amounts of stock options and performance contingent shares excluded from the calculation of common equivalent shares (in thousands):
 
Three months ended March 31,
 
2019
 
2018
Excluded from common equivalent shares:
 
 
 
Stock options
544

 
276

Performance contingent shares
109

 
212


8

Table of Contents


3.
Equity
Common stock
The changes in number of common stock shares, issued, held in treasury and outstanding are as follows for the periods indicated:
 
 
Issued
 
Held In Treasury
 
Outstanding
Balance, December 31, 2018
 
79,137,758

 
16,323,390

 
62,814,368

Common stock acquired
 

 
344,237

 
(344,237
)
Stock-based compensation (1)
 

 
(74,216
)
 
74,216

Balance, March 31, 2019
 
79,137,758

 
16,593,411

 
62,544,347

 
 
Issued
 
Held In Treasury
 
Outstanding
Balance, December 31, 2017
 
79,137,758

 
14,685,663

 
64,452,095

Stock-based compensation (1)
 

 
(60,678
)
 
60,678

Balance, March 31, 2018
 
79,137,758

 
14,624,985

 
64,512,773

(1)
Represents net shares issued from treasury pursuant to the Company’s equity-based compensation programs.
Common Stock Held in Treasury
Common stock held in treasury is accounted for at average cost. Gains resulting from the reissuance of common stock held in treasury are credited to additional paid-in capital. Losses resulting from the reissuance of common stock held in treasury are charged first to additional paid-in capital to the extent the Company has previously recorded gains on treasury share transactions, then to retained earnings.
On January 24, 2019, RGA’s board of directors authorized a share repurchase program for up to $400.0 million of RGA’s outstanding common stock. The authorization was effective immediately and does not have an expiration date. During the three months ended March 31, 2019, RGA repurchased 0.3 million shares of common stock under this program for $50.0 million.
Accumulated Other Comprehensive Income (Loss)
The balance of and changes in each component of accumulated other comprehensive income (loss) (“AOCI”) for the three months ended March 31, 2019 and 2018 are as follows (dollars in thousands):
 
 
Accumulated Other Comprehensive Income (Loss), Net of Income Tax
 
 
Accumulated
Currency
Translation
Adjustments
 
Unrealized
Appreciation
(Depreciation)
of Investments(1)
 
Pension and
Postretirement
Benefits
 
Total
Balance, December 31, 2018
 
$
(168,698
)
 
$
856,159

 
$
(50,698
)
 
$
636,763

Other comprehensive income (loss) before reclassifications
 
18,462

 
1,437,058

 
(1,787
)
 
1,453,733

Amounts reclassified to (from) AOCI
 


 
(14,694
)
 
1,286

 
(13,408
)
Deferred income tax benefit (expense)
 
2,924

 
(314,153
)
 
106

 
(311,123
)
Balance, March 31, 2019
 
$
(147,312
)
 
$
1,964,370

 
$
(51,093
)
 
$
1,765,965

 
 
Accumulated Other Comprehensive Income (Loss), Net of Income Tax
 
 
Accumulated
Currency
Translation
Adjustments
 
Unrealized
Appreciation
(Depreciation)
of Investments(1)
 
Pension and
Postretirement
Benefits
 
Total
Balance, December 31, 2017
 
$
(86,350
)
 
$
2,200,661

 
$
(50,680
)
 
$
2,063,631

Other comprehensive income (loss) before reclassifications
 
5,696

 
(827,701
)
 
(1,910
)
 
(823,915
)
Amounts reclassified to (from) AOCI
 

 
21,274

 
1,346

 
22,620

Deferred income tax benefit (expense)
 
(6,856
)
 
172,823

 
93

 
166,060

Balance, March 31, 2018
 
$
(87,510
)
 
$
1,567,057

 
$
(51,151
)
 
$
1,428,396

(1)
Includes cash flow hedges of $(1,902) and $8,788 as of March 31, 2019 and December 31, 2018, respectively, and $20,662 and $2,619 as of March 31, 2018 and December 31, 2017, respectively. See Note 5 - “Derivative Instruments” for additional information on cash flow hedges.





9

Table of Contents


The following table presents the amounts of AOCI reclassifications for the three months ended March 31, 2019 and 2018 (dollars in thousands):
 
 
Amount Reclassified from AOCI
 
 
 
 
Three months ended March 31,
 
 
Details about AOCI Components
 
2019
 
2018
 
Affected Line Item in 
Statement of Income
Net unrealized investment gains (losses):
 
 
 
 
 
 
Net unrealized gains (losses) on available-for-sale securities
 
$
(273
)
 
$
(14,456
)
 
Investment related gains (losses), net
Cash flow hedges - Interest rate
 
469

 
(370
)
 
(1)
Cash flow hedges - Currency/Interest rate
 
25

 
144

 
(1)
Deferred policy acquisition costs attributed to unrealized gains and losses
 
14,473

 
(6,592
)
 
(2)
Total
 
14,694

 
(21,274
)
 
 
Provision for income taxes
 
(3,006
)
 
4,678

 
 
Net unrealized gains (losses), net of tax
 
$
11,688

 
$
(16,596
)
 
 
Amortization of defined benefit plan items:
 
 
 
 
 
 
Prior service cost (credit)
 
$
269

 
$
246

 
(3)
Actuarial gains/(losses)
 
(1,555
)
 
(1,592
)
 
(3)
Total
 
(1,286
)
 
(1,346
)
 
 
Provision for income taxes
 
270

 
283

 
 
Amortization of defined benefit plans, net of tax
 
$
(1,016
)
 
$
(1,063
)
 
 
 
 
 
 
 
 
 
Total reclassifications for the period
 
$
10,672

 
$
(17,659
)
 
 
(1)
See Note 5 - “Derivative Instruments” for additional information on cash flow hedges.
(2)
This AOCI component is included in the computation of the deferred policy acquisition cost. See Note 8 – “Deferred Policy Acquisition Costs” of the 2018 Annual Report for additional details.
(3)
This AOCI component is included in the computation of the net periodic pension cost. See Note 10 – “Employee Benefit Plans” for additional details.

Equity Based Compensation
Equity compensation expense was $7.6 million and $9.7 million for the three months ended March 31, 2019 and 2018, respectively. In the first quarter of 2019, the Company granted 0.2 million stock appreciation rights at $145.25 weighted average exercise price per share and 0.1 million performance contingent units to employees. As of March 31, 2019, 1.6 million share options at a weighted average strike price per share of $74.36 were vested and exercisable, with a remaining weighted average exercise period of 4.5 years. As of March 31, 2019, the total compensation cost of non-vested awards not yet recognized in the condensed consolidated financial statements was $32.8 million. It is estimated that these costs will vest over a weighted average period of 1.2 years.

10

Table of Contents


4.
Investments
Fixed Maturity Securities Available-for-Sale
The Company holds various types of fixed maturity securities available-for-sale and classifies them as corporate securities (“Corporate”), Canadian and Canadian provincial government securities (“Canadian government”), residential mortgage-backed securities (“RMBS”), asset-backed securities (“ABS”), commercial mortgage-backed securities (“CMBS”), U.S. government and agencies (“U.S. government”), state and political subdivisions, and other foreign government, supranational and foreign government-sponsored enterprises (“Other foreign government”).
The following tables provide information relating to investments in fixed maturity securities by sector as of March 31, 2019 and December 31, 2018 (dollars in thousands):
March 31, 2019:
 
Amortized
 
Unrealized
 
Unrealized
 
Estimated Fair
 
% of
 
Other-than-
temporary impairments
 
 
Cost
 
Gains
 
Losses
 
Value
 
Total
 
in AOCI
Available-for-sale:
 
 
 
 
 
 
 
 
 
 
 
 
Corporate
 
$
24,216,876

 
$
1,024,557

 
$
164,095

 
$
25,077,338

 
60.1
%
 
$

Canadian government
 
2,870,018

 
1,408,501

 
655

 
4,277,864

 
10.2

 

RMBS
 
1,969,694

 
34,746

 
10,254

 
1,994,186

 
4.8

 

ABS
 
2,243,449

 
14,286

 
15,749

 
2,241,986

 
5.4

 
275

CMBS
 
1,404,852

 
30,009

 
3,115

 
1,431,746

 
3.4

 

U.S. government
 
1,578,975

 
9,826

 
21,238

 
1,567,563

 
3.8

 

State and political subdivisions
 
738,690

 
56,668

 
2,641

 
792,717

 
1.9

 

Other foreign government
 
4,166,073

 
201,446

 
12,476

 
4,355,043

 
10.4

 

Total fixed maturity securities
 
$
39,188,627

 
$
2,780,039

 
$
230,223

 
$
41,738,443

 
100.0
%
 
$
275

 
December 31, 2018:
 
Amortized
 
Unrealized
 
Unrealized
 
Estimated Fair
 
% of
 
Other-than-
temporary impairments
 
 
Cost
 
Gains
 
Losses
 
Value
 
Total
 
in AOCI
Available-for-sale:
 
 
 
 
 
 
 
 
 
 
 
 
Corporate
 
$
24,006,407

 
$
530,804

 
$
555,092

 
$
23,982,119

 
59.9
%
 
$

Canadian government
 
2,768,466

 
1,126,227

 
2,308

 
3,892,385

 
9.7

 

RMBS
 
1,872,236

 
22,267

 
25,282

 
1,869,221

 
4.7

 

ABS
 
2,171,254

 
10,779

 
32,829

 
2,149,204

 
5.4

 
275

CMBS
 
1,428,115

 
9,153

 
18,234

 
1,419,034

 
3.5

 

U.S. government
 
2,233,537

 
10,204

 
57,867

 
2,185,874

 
5.5

 

State and political subdivisions
 
721,290

 
39,914

 
9,010

 
752,194

 
1.9

 

Other foreign government
 
3,680,863

 
109,320

 
47,868

 
3,742,315

 
9.4

 

Total fixed maturity securities
 
$
38,882,168

 
$
1,858,668

 
$
748,490

 
$
39,992,346

 
100.0
%
 
$
275

The Company enters into various collateral arrangements with counterparties that require both the pledging and acceptance of fixed maturity securities as collateral. Pledged fixed maturity securities are included in fixed maturity securities, available-for-sale in the condensed consolidated balance sheets. Fixed maturity securities received as collateral are held in separate custodial accounts and are not recorded on the Company’s condensed consolidated balance sheets. Subject to certain constraints, the Company is permitted by contract to sell or repledge collateral it receives; however, as of March 31, 2019 and December 31, 2018, none of the collateral received had been sold or repledged. The Company also holds assets in trust to satisfy collateral requirements under derivative transactions and certain third-party reinsurance treaties. The following table includes fixed maturity securities pledged and received as collateral and assets in trust held to satisfy collateral requirements under derivative transactions and certain third-party reinsurance treaties as of March 31, 2019 and December 31, 2018 (dollars in thousands):
 
March 31, 2019
 
December 31, 2018
 
Amortized
Cost
 
Estimated
Fair Value
 
Amortized
Cost
 
Estimated
Fair Value
Fixed maturity securities pledged as collateral
$
74,647

 
$
77,806

 
$
80,891

 
$
83,950

Fixed maturity securities received as collateral
n/a

 
668,046

 
n/a

 
616,584

Assets in trust held to satisfy collateral requirements
20,635,739

 
21,609,979

 
20,072,735

 
20,366,170


11

Table of Contents


The Company monitors its concentrations of financial instruments on an ongoing basis and mitigates credit risk by maintaining a diversified investment portfolio that limits exposure to any one issuer. The Company’s exposure to concentrations of credit risk from single issuers greater than 10% of the Company’s stockholders’ equity included securities of the U.S. government and its agencies as well as the securities disclosed below as of March 31, 2019 and December 31, 2018 (dollars in thousands).
 
March 31, 2019
 
December 31, 2018
 
Amortized
Cost
 
Estimated
Fair Value
 
Amortized
Cost
 
Estimated
Fair Value
Fixed maturity securities guaranteed or issued by:
 
 
 
 
 
 
 
Canadian province of Quebec
$
1,128,373

 
$
1,955,925

 
$
1,091,018

 
$
1,757,087

Canadian province of Ontario
946,731

 
1,287,150

 
913,642

 
1,187,526

The amortized cost and estimated fair value of fixed maturity securities classified as available-for-sale as of March 31, 2019 are shown by contractual maturity in the table below (dollars in thousands). Actual maturities can differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Asset and mortgage-backed securities are shown separately in the table below, as they are not due at a single maturity date.
 
 
Amortized Cost
 
Estimated Fair Value
Available-for-sale:
 
 
 
 
Due in one year or less
 
$
1,409,578

 
$
1,419,110

Due after one year through five years
 
8,141,200

 
8,340,166

Due after five years through ten years
 
8,933,926

 
9,345,621

Due after ten years
 
15,085,928

 
16,965,628

Asset and mortgage-backed securities
 
5,617,995

 
5,667,918

Total
 
$
39,188,627

 
$
41,738,443

Corporate Fixed Maturity Securities
The tables below show the major industry types of the Company’s corporate fixed maturity holdings as of March 31, 2019 and December 31, 2018 (dollars in thousands): 
March 31, 2019:
 
 
 
Estimated
 
 
 
 
Amortized Cost    
 
Fair Value
 
% of Total           
Finance
 
$
8,981,541

 
$
9,249,273

 
36.9
%
Industrial
 
12,316,131

 
12,759,526

 
50.9

Utility
 
2,919,204

 
3,068,539

 
12.2

Total
 
$
24,216,876

 
$
25,077,338

 
100.0
%
 
 
 
 
 
 
 
December 31, 2018:
 
 
 
Estimated
 
 
 
 
Amortized Cost
 
Fair Value
 
% of Total
Finance
 
$
8,793,742

 
$
8,730,568

 
36.3
%
Industrial
 
12,336,857

 
12,342,111

 
51.6

Utility
 
2,875,808

 
2,909,440

 
12.1

Total
 
$
24,006,407

 
$
23,982,119

 
100.0
%

12

Table of Contents


Other-Than-Temporary Impairments - Fixed Maturity Securities
As discussed in Note 2 – “Significant Accounting Policies and Pronouncements” of the 2018 Annual Report, a portion of certain other-than-temporary impairment (“OTTI”) losses on fixed maturity securities is recognized in AOCI. For these securities, the net amount recognized in the condensed consolidated statements of income (“credit loss impairments”) represents the difference between the amortized cost of the security and the net present value of its projected future cash flows discounted at the effective interest rate implicit in the debt security prior to impairment. Any remaining difference between the fair value and amortized cost is recognized in AOCI. The amount of pre-tax credit loss impairments on fixed maturity securities held by the Company, for which a portion of the OTTI loss was recognized in AOCI, was $3.7 million as of March 31, 2019 and 2018. There were no changes in these amounts from their respective prior-year ending balances.
Unrealized Losses for Fixed Maturity Securities Available-for-Sale
The following table presents the total gross unrealized losses for the 1,585 and 3,109 fixed maturity securities as of March 31, 2019 and December 31, 2018, respectively, where the estimated fair value had declined and remained below amortized cost by the indicated amount (dollars in thousands):
 
 
March 31, 2019
 
December 31, 2018
 
 
Gross
Unrealized
Losses
 
% of Total    
 
Gross
Unrealized
Losses
 
% of Total    
Less than 20%
 
$
208,034

 
90.3
%
 
$
721,015

 
96.3
%
20% or more for less than six months
 
20,845

 
9.1

 
21,336

 
2.9

20% or more for six months or greater
 
1,344

 
0.6

 
6,139

 
0.8

Total
 
$
230,223

 
100.0
%
 
$
748,490

 
100.0
%
The Company’s determination of whether a decline in value is other-than-temporary includes an analysis of the underlying credit and the extent and duration of a decline in value. The Company’s credit analysis of an investment includes determining whether the issuer is current on its contractual payments, evaluating whether it is probable that the Company will be able to collect all amounts due according to the contractual terms of the security and analyzing the overall ability of the Company to recover the amortized cost of the investment.
The following tables present the estimated fair values and gross unrealized losses, including other-than-temporary impairment losses reported in AOCI, for 1,585 and 3,109 fixed maturity securities that have estimated fair values below amortized cost as of March 31, 2019 and December 31, 2018, respectively (dollars in thousands). These investments are presented by class and grade of security, as well as the length of time the related fair value has remained below amortized cost.
 
 
 
Less than 12 months
 
12 months or greater
 
Total
 
 
 
 
Gross
 
 
 
Gross
 
 
 
Gross
March 31, 2019:
 
Estimated
 
Unrealized
 
Estimated
 
Unrealized
 
Estimated
 
Unrealized
 
 
Fair Value
 
Losses
 
Fair Value
 
Losses
 
Fair Value
 
Losses
Investment grade securities:
 
 
 
 
 
 
 
 
 
 
 
 
Corporate
 
$
1,140,753

 
$
23,578

 
$
3,756,371

 
$
108,434

 
$
4,897,124

 
$
132,012

Canadian government
 
2,812

 
19

 
72,244

 
636

 
75,056

 
655

RMBS
 
29,505

 
122

 
672,715

 
10,109

 
702,220

 
10,231

ABS
 
774,538

 
7,246

 
528,169

 
8,472

 
1,302,707

 
15,718

CMBS
 
100,664

 
369

 
227,404

 
2,746

 
328,068

 
3,115

U.S. government
 
1,265

 
1

 
1,125,274

 
21,237

 
1,126,539

 
21,238

State and political subdivisions
 
31,416

 
149

 
113,463

 
2,492

 
144,879

 
2,641

Other foreign government
 
115,581

 
2,813

 
345,928

 
7,213

 
461,509

 
10,026

Total investment grade securities
 
2,196,534

 
34,297

 
6,841,568

 
161,339

 
9,038,102

 
195,636

 
Below investment grade securities:
 
 
 
 
 
 
 
 
 
 
 
 
Corporate
 
215,368

 
21,398

 
161,915

 
10,685

 
377,283

 
32,083

RMBS
 

 

 
1,001

 
23

 
1,001

 
23

ABS
 

 

 
1,029

 
31

 
1,029

 
31

Other foreign government
 
27,413

 
838

 
27,301

 
1,612

 
54,714

 
2,450

Total below investment grade securities
 
242,781

 
22,236

 
191,246

 
12,351

 
434,027

 
34,587

Total fixed maturity securities
 
$
2,439,315

 
$
56,533

 
$
7,032,814

 
$
173,690

 
$
9,472,129

 
$
230,223


13

Table of Contents


 
 
Less than 12 months
 
12 months or greater
 
Total
 
 
 
 
Gross
 
 
 
Gross
 
 
 
Gross
December 31, 2018:
 
Estimated
 
Unrealized
 
Estimated
 
Unrealized
 
Estimated
 
Unrealized
 
 
Fair Value
 
Losses
 
Fair Value
 
Losses
 
Fair Value
 
Losses
Investment grade securities:
 
 
 
 
 
 
 
 
 
 
 
 
Corporate
 
$
8,505,371

 
$
302,604

 
$
3,611,266

 
$
195,082

 
$
12,116,637

 
$
497,686

Canadian government
 
25,169

 
419

 
131,806

 
1,612

 
156,975

 
2,031

RMBS
 
269,558

 
2,488

 
836,741

 
22,760

 
1,106,299

 
25,248

ABS
 
1,102,677

 
24,271

 
381,609

 
8,523

 
1,484,286

 
32,794

CMBS
 
384,259

 
4,304

 
414,719

 
13,930

 
798,978

 
18,234

U.S. government
 
8,616

 
80

 
1,086,694

 
57,787

 
1,095,310

 
57,867

State and political subdivisions
 
103,504

 
1,538

 
157,330

 
7,472

 
260,834

 
9,010

Other foreign government
 
789,859

 
24,509

 
472,934

 
17,446

 
1,262,793

 
41,955

Total investment grade securities
 
11,189,013

 
360,213

 
7,093,099

 
324,612

 
18,282,112

 
684,825

Below investment grade securities:
 
 
 
 
 
 
 
 
 
 
 
 
Corporate
 
755,679

 
42,760

 
122,559

 
14,646

 
878,238

 
57,406

Canadian government
 
443

 
34

 
1,770

 
243

 
2,213

 
277

RMBS
 

 

 
1,026

 
34

 
1,026

 
34

ABS
 

 

 
1,063

 
35

 
1,063

 
35

Other foreign government
 
128,725

 
5,574

 
7,479

 
339

 
136,204

 
5,913

Total below investment grade securities
 
884,847

 
48,368

 
133,897

 
15,297

 
1,018,744

 
63,665

Total fixed maturity securities
 
$
12,073,860

 
$
408,581

 
$
7,226,996


$
339,909

 
$
19,300,856

 
$
748,490


The Company has no intention to sell, nor does it expect to be required to sell, the securities outlined in the table above, as of the dates indicated. However, unforeseen facts and circumstances may cause the Company to sell fixed maturity securities in the ordinary course of managing its portfolio to meet certain diversification, credit quality and liquidity guidelines. Changes in unrealized losses are primarily driven by changes in interest rates.

Investment Income, Net of Related Expenses
Major categories of investment income, net of related expenses, consist of the following (dollars in thousands):
 
 
Three months ended March 31,
 
2019
 
2018
Fixed maturity securities available-for-sale
$
415,087

 
$
369,203

Equity securities
1,246

 
1,682

Mortgage loans on real estate
59,562

 
50,199

Policy loans
14,109

 
14,780

Funds withheld at interest
61,734

 
75,445

Short-term investments and cash and cash equivalents
6,900

 
3,245

Other invested assets
42,236

 
23,828

Investment income
600,874

 
538,382

Investment expense
(20,997
)
 
(22,053
)
Investment income, net of related expenses
$
579,877

 
$
516,329


14

Table of Contents


Investment Related Gains (Losses), Net
Investment related gains (losses), net, consist of the following (dollars in thousands): 
 
Three months ended March 31,
 
2019
 
2018
Fixed maturity securities available-for-sale:
 
 
 
Other-than-temporary impairment losses
$
(9,453
)
 
$

Gain on investment activity
28,045

 
10,966

Loss on investment activity
(18,723
)
 
(20,380
)
Equity securities:
 
 
 
Gain on investment activity
74

 
28

Loss on investment activity
(1
)
 
(950
)
Change in unrealized gains (losses) recognized in earnings
3,744

 
(4,137
)
Other impairment losses and change in mortgage loan provision
(1,859
)
 
(312
)
Derivatives and other, net
5,961

 
14,315

Total investment related gains (losses), net
$
7,788

 
$
(470
)
The fixed maturity impairments for the three months ended March 31, 2019 were largely related to a U.S. utility company. There were no fixed maturity impairments for the three months ended March 31, 2018. The other impairment losses and change in mortgage loan provision for the three months ended March 31, 2019 were primarily due to impairments on real estate joint ventures and an increase of the equity release mortgage valuation allowance. The other impairment losses and change in mortgage loan provision for the three months ended March 31, 2018 were primarily due to impairments on real estate joint ventures offset by a release of the mortgage loan valuation allowance. The fluctuations in investment related gains (losses) for derivatives and other for the three months ended March 31, 2019, compared to the same period in 2018, are primarily due to changes in the fair value of embedded derivatives, futures and equity options offset by interest rate swaps.
During the three months ended March 31, 2019 and 2018, the Company sold fixed maturity securities with fair values of $1,246.6 million and $1,263.6 million at losses of $18.7 million and $20.4 million, respectively. During the three months ended March 31, 2019, the Company sold equity securities for immaterial losses. During the three months ended March 31, 2018, the Company sold equity securities with fair values of $28.4 million at losses of $1.0 million. The Company generally does not buy and sell securities on a short-term basis.
Securities Borrowing, Lending and Other
The following table includes the amount of borrowed securities, securities lent and securities collateral received as part of the securities lending program and repurchased/reverse repurchased securities pledged and received as of March 31, 2019 and December 31, 2018 (dollars in thousands).
 
March 31, 2019
 
December 31, 2018
 
Amortized
Cost
 
Estimated
Fair Value
 
Amortized
Cost
 
Estimated
Fair Value
Borrowed securities
$
339,593

 
$
371,473

 
$
335,781

 
$
366,663

Securities lending:
 
 
 
 
 
 
 
Securities loaned
97,510

 
100,665

 
101,981

 
102,618

Securities received
n/a

 
107,000

 
n/a

 
112,000

Repurchase program/reverse repurchase program:
 
 
 
 
 
 
 
Securities pledged
548,100

 
558,981

 
554,806

 
554,589

Securities received
n/a

 
558,523

 
n/a

 
530,932

The Company also held cash collateral for repurchase program/reverse repurchase programs of $28.7 million and $28.6 million at March 31, 2019 and December 31, 2018, respectively. No cash or securities have been pledged by the Company for its securities borrowing program as of March 31, 2019 and December 31, 2018.
The following tables present information on the Company’s securities lending and repurchase transactions as of March 31, 2019 and December 31, 2018 (dollars in thousands). Collateral associated with certain borrowed securities is not included within the tables, as the collateral pledged to each counterparty is the right to reinsurance treaty cash flows.

15

Table of Contents


 
March 31, 2019
 
Remaining Contractual Maturity of the Agreements
 
Overnight and Continuous
 
Up to 30 Days
 
30-90 Days
 
Greater than 90 Days
 
Total
Securities lending transactions:
 
 
 
 
 
 
 
 
 
Corporate
$

 
$

 
$

 
$
100,665

 
$
100,665

Total

 

 

 
100,665

 
100,665

Repurchase transactions:
 
 
 
 
 
 
 
 
 
Corporate

 

 

 
267,846

 
267,846

U.S. government

 

 
43,657

 
165,272

 
208,929

Foreign government

 

 

 
82,206

 
82,206

Total

 

 
43,657

 
515,324

 
558,981

Total borrowings
$

 
$

 
$
43,657

 
$
615,989

 
$
659,646

 
 
 
 
 
 
 
 
 
 
Gross amount of recognized liabilities for securities lending and repurchase transactions in preceding table
 
$
694,271

Amounts related to agreements not included in offsetting disclosure
 
$
34,625

 
December 31, 2018
 
Remaining Contractual Maturity of the Agreements
 
Overnight and Continuous
 
Up to 30 Days
 
30-90 Days
 
Greater than 90 Days
 
Total
Securities lending transactions:
 
 
 
 
 
 
 
 
 
Corporate
$

 
$

 
$

 
$
102,618

 
$
102,618

Total

 

 

 
102,618

 
102,618

Repurchase transactions:
 
 
 
 
 
 
 
 
 
Corporate

 

 

 
254,151

 
254,151

U.S. government

 

 

 
221,572

 
221,572

Foreign government

 

 

 
78,866

 
78,866

Total

 

 

 
554,589

 
554,589

Total borrowings
$

 
$

 
$

 
$
657,207

 
$
657,207

 
 
 
 
 
 
 
 
 

Gross amount of recognized liabilities for securities lending and repurchase transactions in preceding table
 
$
671,492

Amounts related to agreements not included in offsetting disclosure
 
$
14,285

The Company has elected to offset amounts recognized as receivables and payables resulting from the repurchase/reverse repurchase programs. After the effect of offsetting, the net amount presented on the condensed consolidated balance sheets was a liability of $0.4 million as of both March 31, 2019 and December 31, 2018. As of March 31, 2019 and December 31, 2018, the Company recognized payables resulting from cash received as collateral associated with a repurchase agreement, as discussed above. Amounts owed to and due from the counterparties may be settled in cash or offset, in accordance with the agreements.

16

Table of Contents


Mortgage Loans on Real Estate
Mortgage loans represented approximately 9.1% of the Company’s total investments as of both March 31, 2019 and December 31, 2018. As of March 31, 2019, mortgage loans were geographically dispersed throughout the U.S. with the largest concentrations in California (17.7%), Texas (11.8%) and Washington (7.1%) and include loans secured by properties in Canada (2.9%) and United Kingdom (0.5%). The recorded investment in mortgage loans on real estate presented below is gross of unamortized deferred loan origination fees and expenses, and valuation allowances.
The distribution of mortgage loans by property type is as follows as of March 31, 2019 and December 31, 2018 (dollars in thousands):
 
 
 
March 31, 2019
 
December 31, 2018
 Property type:
 
Carrying Value
 
% of Total
 
Carrying Value
 
% of Total
Office building
 
$
1,707,764

 
33.3
%
 
$
1,725,748

 
34.6
%
Retail
 
1,495,883

 
29.1

 
1,432,394

 
28.7

Industrial
 
1,021,871

 
19.9

 
961,924

 
19.3

Apartment
 
620,926

 
12.1

 
571,291

 
11.5

Other commercial
 
288,454

 
5.6

 
291,997

 
5.9

Recorded investment
 
$
5,134,898

 
100.0
%
 
$
4,983,354

 
100.0
%
Unamortized balance of loan origination fees and expenses
 
(6,135
)
 
 
 
(5,770
)
 
 
Valuation allowances
 
(11,218
)
 
 
 
(11,286
)
 
 
Total mortgage loans on real estate
 
$
5,117,545

 
 
 
$
4,966,298

 
 
The maturities of mortgage loans as of March 31, 2019 and December 31, 2018 are as follows (dollars in thousands):
 
 
 
March 31, 2019
 
December 31, 2018
 
 
Recorded
Investment
 
% of Total
 
Recorded
Investment
 
% of Total
Due within five years
 
$
1,449,925

 
28.2
%
 
$
1,425,598

 
28.6
%
Due after five years through ten years
 
2,833,275

 
55.2

 
2,686,264

 
53.9

Due after ten years
 
851,698

 
16.6

 
871,492

 
17.5

Total
 
$
5,134,898

 
100.0
%
 
$
4,983,354

 
100.0
%
The following tables set forth certain key credit quality indicators of the Company’s recorded investment in mortgage loans as of March 31, 2019 and December 31, 2018 (dollars in thousands):
 
Recorded Investment
 
Debt Service Ratios
 
Construction loans
 
 
 
 
 
>1.20x
 
1.00x - 1.20x
 
<1.00x
 
 
Total
 
% of Total
March 31, 2019:
 
 
 
 
 
 
 
 
 
 
 
Loan-to-Value Ratio
 
 
 
 
 
 
 
 
 
 
 
0% - 59.99%
$
2,477,507

 
$
87,802

 
$
36,998

 
$
16,556

 
$
2,618,863

 
51.0
%
60% - 69.99%
1,692,549

 
78,559

 
41,680

 
21,051

 
1,833,839

 
35.7

70% - 79.99%
403,173

 
27,591

 
42,008

 

 
472,772

 
9.2

Greater than 80%
117,390

 
49,522

 
42,512

 

 
209,424

 
4.1

Total
$
4,690,619

 
$
243,474

 
$
163,198

 
$
37,607

 
$
5,134,898

 
100.0
%

17

Table of Contents


 
Recorded Investment
 
Debt Service Ratios
 
Construction loans
 
 
 
 
 
>1.20x
 
1.00x - 1.20x
 
<1.00x
 
 
Total
 
% of Total
December 31, 2018:
 
 
 
 
 
 
 
 
 
 
 
Loan-to-Value Ratio
 
 
 
 
 
 
 
 
 
 
 
0% - 59.99%
$
2,410,556

 
$
61,246

 
$
38,177

 
$
13,691

 
$
2,523,670

 
50.6
%
60% - 69.99%
1,618,374

 
73,908

 
38,120

 
18,929

 
1,749,331

 
35.1

70% - 79.99%
414,269

 
48,438

 
54,440

 

 
517,147

 
10.4

Greater than 80%
117,978

 
49,668

 
25,560

 

 
193,206

 
3.9

Total
$
4,561,177

 
$
233,260

 
$
156,297

 
$
32,620

 
$
4,983,354

 
100.0
%
The age analysis of the Company’s past due recorded investments in mortgage loans as of March 31, 2019 and December 31, 2018 is as follows (dollars in thousands):
 
 
March 31, 2019
 
December 31, 2018
31-60 days past due
 
$
11,795

 
$

61-90 days past due
 
17,079

 

Total past due
 
28,874

 

Current
 
5,106,024

 
4,983,354

Total
 
$
5,134,898

 
$
4,983,354

The following table presents the recorded investment in mortgage loans, by method of measuring impairment, and the related valuation allowances as of March 31, 2019 and December 31, 2018 (dollars in thousands):
 
 
March 31, 2019
 
December 31, 2018
Mortgage loans:
 
 
 
 
Individually measured for impairment
 
$
17,079

 
$
30,635

Collectively measured for impairment
 
5,117,819

 
4,952,719

Recorded investment
 
$
5,134,898

 
$
4,983,354

Valuation allowances:
 
 
 
 
Individually measured for impairment
 
$

 
$

Collectively measured for impairment
 
11,218

 
11,286

Total valuation allowances
 
$
11,218

 
$
11,286

Information regarding the Company’s loan valuation allowances for mortgage loans for the three months ended March 31, 2019 and 2018 is as follows (dollars in thousands):
 
Three months ended March 31,
 
2019
 
2018
Balance, beginning of period
$
11,286

 
$
9,384

Provision (release)
(73
)
 
(516
)
Translation adjustment
5

 
(4
)
Balance, end of period
$
11,218

 
$
8,864



18

Table of Contents


Information regarding the portion of the Company’s mortgage loans that were impaired as of March 31, 2019 and December 31, 2018 is as follows (dollars in thousands):
 
 
Unpaid
Principal
Balance
 
Recorded
Investment
 
Related
Allowance
 
Carrying
Value
March 31, 2019:
 
 
 
 
 
 
 
 
Impaired mortgage loans with no valuation allowance recorded
 
$
17,084

 
$
17,079

 
$

 
$
17,079

Impaired mortgage loans with valuation allowance recorded
 

 

 

 

Total impaired mortgage loans
 
$
17,084

 
$
17,079

 
$

 
$
17,079

December 31, 2018:
 
 
 
 
 
 
 
 
Impaired mortgage loans with no valuation allowance recorded
 
$
30,660

 
$
30,635

 
$

 
$
30,635

Impaired mortgage loans with valuation allowance recorded
 

 

 

 

Total impaired mortgage loans
 
$
30,660

 
$
30,635

 
$

 
$
30,635

 
 
 
 
 
 
 
 
 
The Company’s average investment balance of impaired mortgage loans and the related interest income are reflected in the table below for the periods indicated (dollars in thousands):
 
 
Three months ended March 31,
 
 
2019
 
2018
 
 
Average
Recorded
Investment
(1)
 
Interest
Income
 
Average
Recorded
Investment
(1)
 
Interest
Income
Impaired mortgage loans with no valuation allowance recorded
 
$
23,857

 
$
328

 
$
14,640

 
$
56

Impaired mortgage loans with valuation allowance recorded
 

 

 

 

Total impaired mortgage loans
 
$
23,857

 
$
328

 
$
14,640

 
$
56

(1) Average recorded investment represents the average loan balances as of the beginning of period and all subsequent quarterly end of period balances.

The Company did not acquire any impaired mortgage loans during the three months ended March 31, 2019 and 2018. The Company had no mortgage loans that were on a nonaccrual status as of March 31, 2019 and December 31, 2018.

Policy Loans
Policy loans comprised approximately 2.3% and 2.5% of the Company’s total investments as of March 31, 2019 and December 31, 2018, respectively, the majority of which are associated with one client. These policy loans present no credit risk because the amount of the loan cannot exceed the obligation due to the ceding company upon the death of the insured or surrender of the underlying policy. The provisions of the treaties in force and the underlying policies determine the policy loan interest rates. The Company earns a spread between the interest rate earned on policy loans and the interest rate credited to corresponding liabilities.
Funds Withheld at Interest
Funds withheld at interest comprised approximately 10.2% and 10.6% of the Company’s total investments as of March 31, 2019 and December 31, 2018, respectively. Of the $5.7 billion funds withheld at interest balance, net of embedded derivatives, as of March 31, 2019, $3.7 billion of the balance is associated with one client. For reinsurance agreements written on a modified coinsurance basis and certain agreements written on a coinsurance funds withheld basis, assets equal to the net statutory reserves are withheld and legally owned and managed by the ceding company and are reflected as funds withheld at interest on the Company’s condensed consolidated balance sheets. In the event of a ceding company’s insolvency, the Company would need to assert a claim on the assets supporting its reserve liabilities. However, the risk of loss to the Company is mitigated by its ability to offset amounts it owes the ceding company for claims or allowances against amounts owed to the Company from the ceding company.
Other Invested Assets
Other invested assets represented approximately 3.6% and 3.5% of the Company’s total investments as of March 31, 2019 and December 31, 2018, respectively. Carrying values of these assets as of March 31, 2019 and December 31, 2018 are as follows (dollars in thousands):
 
 
March 31, 2019
 
December 31, 2018
Limited partnership interests and real estate joint ventures
 
$
982,592

 
$
965,094

Equity release mortgages
 
595,559

 
475,905

Derivatives
 
132,412

 
180,699

FVO contractholder-directed unit-linked investments
 
202,848

 
197,770

Other
 
93,459

 
95,829

Total other invested assets
 
$
2,006,870

 
$
1,915,297


19

Table of Contents


5.    Derivative Instruments
Accounting for Derivative Instruments and Hedging Activities
See Note 2 – “Significant Accounting Policies and Pronouncements” of the Company’s 2018 Annual Report for a detailed discussion of the accounting treatment for derivative instruments, including embedded derivatives. See Note 6 – “Fair Value of Assets and Liabilities” for additional disclosures related to the fair value hierarchy for derivative instruments, including embedded derivatives.
Types of Derivatives Used by the Company
The Company utilizes various derivative instruments and strategies to manage its risks. Commonly used derivative instruments include, but are not necessarily limited to: credit default swaps, financial futures, equity options, foreign currency swaps, foreign currency forwards, interest rate swaps, synthetic guaranteed investment contracts (“GICs”), consumer price index (“CPI”) swaps, longevity swaps, mortality swaps and embedded derivatives.
For detailed information on these derivative instruments and the related strategies, see Note 5 – “Derivative Instruments” of the Company’s 2018 Annual Report.
Summary of Derivative Positions
Derivatives, except for embedded derivatives and longevity and mortality swaps, are carried on the Company’s condensed consolidated balance sheets in other invested assets or other liabilities, at fair value. Longevity and mortality swaps are included on the condensed consolidated balance sheets in other assets or other liabilities, at fair value. Embedded derivative assets and liabilities on modified coinsurance (“modco”) or funds withheld arrangements are included on the condensed consolidated balance sheets with the host contract in funds withheld at interest, at fair value. Embedded derivative liabilities on indexed annuity and variable annuity products are included on the condensed consolidated balance sheets with the host contract in interest-sensitive contract liabilities, at fair value. The following table presents the notional amounts and gross fair value of derivative instruments prior to taking into account the netting effects of master netting agreements as of March 31, 2019 and December 31, 2018 (dollars in thousands):
 
 
 
 
March 31, 2019
 
December 31, 2018
 
 
Primary Underlying Risk
 
Notional
 
Carrying Value/Fair Value
 
Notional
 
Carrying Value/Fair Value
 
 
 
Amount
 
Assets
 
Liabilities
 
Amount
 
Assets
 
Liabilities
Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
 
Interest rate
 
$
1,018,438

 
$
57,278

 
$
2,670

 
$
1,040,588

 
$
47,652

 
$
961

Financial futures
 
Equity
 
360,170

 

 

 
325,620

 

 

Foreign currency swaps
 
Foreign currency
 
149,698

 

 
4,629

 
149,698

 
504

 
4,659

Foreign currency forwards
 
Foreign currency
 
25,000

 
251

 

 
25,000

 

 
234

CPI swaps
 
CPI
 
388,151

 

 
20,505

 
385,580

 

 
11,384

Credit default swaps
 
Credit
 
1,348,300

 
6,614

 
58

 
1,338,300

 
6,003

 
1,166

Equity options
 
Equity
 
439,158

 
20,152

 

 
439,158

 
42,836

 

Longevity swaps
 
Longevity
 
897,440

 
48,869

 

 
917,360

 
47,789

 

Mortality swaps
 
Mortality
 
25,000

 
489

 

 
25,000

 

 
369

Synthetic GICs
 
Interest rate
 
13,895,380

 

 

 
13,397,729

 

 

Embedded derivatives in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Modco or funds withheld arrangements
 
 
 

 
107,506

 

 

 
109,597

 

Indexed annuity products
 
 
 

 

 
754,171

 

 

 
776,940

Variable annuity products
 
 
 

 

 
149,764

 

 

 
167,925

Total non-hedging derivatives
 
 
 
18,546,735

 
241,159

 
931,797

 
18,044,033

 
254,381

 
963,638

Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
 
Foreign currency/Interest rate
 
435,000

 
891

 
24,436

 
435,000

 

 
27,257

Foreign currency swaps
 
Foreign currency
 
451,686

 
38,620

 
479

 
494,461

 
51,311

 

Foreign currency forwards
 
Foreign currency
 
949,879

 
32,862

 

 
911,197

 
50,974

 

Total hedging derivatives
 
 
 
1,836,565

 
72,373

 
24,915

 
1,840,658

 
102,285

 
27,257

Total derivatives
 
 
 
$
20,383,300

 
$
313,532

 
$
956,712

 
$
19,884,691

 
$
356,666

 
$
990,895




20

Table of Contents


Fair Value Hedges
The Company designates and reports certain foreign currency swaps to hedge the foreign currency fair value exposure of foreign currency denominated assets as fair value hedges when they meet the requirements of the general accounting principles for Derivatives and Hedging. The gain or loss on the hedged item attributable to a change in foreign currency and the offsetting gain or loss on the related foreign currency swaps as of March 31, 2019 and 2018, were (dollars in thousands):
Type of Fair Value Hedge
 
Hedged Item
 
Gains (Losses) Recognized for Derivatives
 
Gains (Losses) Recognized for Hedged Items
 
 
 
 
Investment Related Gains (Losses)
For the three months ended March 31, 2019:
 
 
 
 
Foreign currency swaps
 
Foreign-denominated fixed maturity securities
 
$
(709
)
 
$
(703
)
For the three months ended March 31, 2018:
Foreign currency swaps
 
Foreign-denominated fixed maturity securities
 
$
(1,891
)
 
$
1,891

Cash Flow Hedges
Certain derivative instruments are designated as cash flow hedges when they meet the requirements of the general accounting principles for Derivatives and Hedging. The Company designates and accounts for the following as cash flows: (i) certain interest rate swaps, in which the cash flows of liabilities are variable based on a benchmark rate; and (ii) certain interest rate swaps, in which the cash flows of assets are denominated in different currencies, commonly referred to as cross-currency swaps.
The following table presents the components of AOCI, before income tax, and the condensed consolidated income statement classification where the gain or loss is recognized related to cash flow hedges for the three months ended March 31, 2019 and 2018 (dollars in thousands):
 
 
Three months ended March 31,
 
 
2019
 
2018
Balance beginning of period
 
$
8,788

 
$
2,619

Gains (losses) deferred in other comprehensive income (loss)
 
(10,196
)
 
17,817

Amounts reclassified to investment income
 
(25
)
 
(144
)
Amounts reclassified to interest expense
 
(469
)
 
370

Balance end of period
 
$
(1,902
)
 
$
20,662

As of March 31, 2019, the before-tax deferred net gains (losses) on derivative instruments recorded in AOCI that are expected to be reclassified to earnings during the next twelve months are approximately $0.1 million and $1.7 million in investment income and interest expense, respectively.
The following table presents the effect of derivatives in cash flow hedging relationships on the condensed consolidated statements of income and the condensed consolidated statements of comprehensive income for the three months ended March 31, 2019 and 2018 (dollars in thousands):
Derivative Type
 
Gain (Loss) Deferred in OCI
 
Gain (Loss) Reclassified into Income from OCI
 
 
 
 
Investment Income
 
Interest Expense
For the three months ended March 31, 2019:
 
 
 
 
 
 
Interest rate
 
$
(12,101
)
 
$

 
$
469

Currency/Interest rate
 
1,905

 
25

 

Total
 
$
(10,196
)
 
$
25

 
$
469

For the three months ended March 31, 2018:
 
 
 
 
 
 
Interest rate
 
$
14,986

 
$

 
$
(370
)
Currency/Interest rate
 
2,831

 
144

 

Total
 
$
17,817

 
$
144

 
$
(370
)
For the three months ended March 31, 2019 and 2018, there were no material amounts reclassified into earnings relating to instances in which the Company discontinued cash flow hedge accounting because the forecasted transaction did not occur by the anticipated date or within the additional time period permitted by the authoritative guidance for the accounting for derivatives and hedging.

21

Table of Contents


Hedges of Net Investments in Foreign Operations
The Company uses foreign currency swaps and foreign currency forwards to hedge a portion of its net investment in certain foreign operations against adverse movements in exchange rates. The following table illustrates the Company’s net investments in foreign operations (“NIFO”) hedges for the three months ended March 31, 2019 and 2018 (dollars in thousands):
 
 
Derivative Gains (Losses) Deferred in AOCI     
 
 
For the three months ended March 31,
Type of NIFO Hedge (1)
 
2019
 
2018
Foreign currency swaps
 
$
(7,007
)
 
$
8,805

Foreign currency forwards
 
(18,112
)
 
12,236

(1)
There were no sales or substantial liquidations of net investments in foreign operations that would have required the reclassification of gains or losses from accumulated other comprehensive income (loss) into investment income during the periods presented.

The cumulative foreign currency translation gain recorded in AOCI related to these hedges was $175.9 million and $201.0 million at March 31, 2019 and December 31, 2018, respectively. If a hedged foreign operation was sold or substantially liquidated, the amounts in AOCI would be reclassified to the condensed consolidated statements of income. A pro rata portion would be reclassified upon partial sale of a hedged foreign operation.
Non-qualifying Derivatives and Derivatives for Purposes Other Than Hedging
The Company uses various other derivative instruments for risk management purposes that either do not qualify or have not been qualified for hedge accounting treatment. The gain or loss related to the change in fair value for these derivative instruments is recognized in investment related gains (losses), net in the condensed consolidated statements of income, except where otherwise noted.
A summary of the effect of non-hedging derivatives, including embedded derivatives, on the Company’s condensed consolidated statements of income for the three months ended March 31, 2019 and 2018 is as follows (dollars in thousands):
 
 
 
 
Gain (Loss) for the three months ended        
March 31,
Type of Non-hedging Derivative
 
Income Statement Location of Gain (Loss)
 
2019
 
2018
Interest rate swaps
 
Investment related gains (losses), net
 
$
23,974

 
$
(26,571
)
Financial futures
 
Investment related gains (losses), net
 
(22,278
)
 
129

Foreign currency swaps
 
Investment related gains (losses), net
 
723

 

Foreign currency forwards
 
Investment related gains (losses), net
 
492

 
323

CPI swaps
 
Investment related gains (losses), net
 
(8,851
)
 
2,186

Credit default swaps
 
Investment related gains (losses), net
 
14,500

 
(402
)
Equity options
 
Investment related gains (losses), net
 
(22,684
)
 
2,593

Longevity swaps
 
Other revenues
 
2,143

 
2,267

Mortality swaps
 
Other revenues
 
858

 

Subtotal
 
 
 
(11,123
)
 
(19,475
)
Embedded derivatives in:
 
 
 
 
 
 
Modco or funds withheld arrangements
 
Investment related gains (losses), net
 
(2,092
)
 
13,611

Indexed annuity products
 
Interest credited
 
3,070

 
25,351

Variable annuity products
 
Investment related gains (losses), net
 
18,161

 
14,785

Total non-hedging derivatives
 
 
 
$
8,016

 
$
34,272


22

Table of Contents


Credit Derivatives
The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of credit default swaps sold by the Company at March 31, 2019 and December 31, 2018 (dollars in thousands):
 
 
March 31, 2019
 
December 31, 2018
Rating Agency Designation of Referenced Credit Obligations(1)
 
Estimated Fair
Value of Credit  
Default Swaps
 
Maximum
Amount of Future
Payments under
Credit Default
Swaps(2)
 
Weighted
Average
Years to
Maturity(3)
 
Estimated Fair
Value of Credit  
Default Swaps
 
Maximum
Amount of Future
Payments under
Credit Default
Swaps(2)
 
Weighted
Average
Years to
Maturity(3)  
AAA/AA+/AA/AA-/A+/A/A-
 
 
 
 
 
 
 
 
 
 
 
 
Single name credit default swaps
 
$
2,082

 
$
157,000

 
2.1
 
$
1,953

 
$
152,000

 
2.2
Subtotal
 
2,082

 
157,000

 
2.1
 
1,953

 
152,000

 
2.2
BBB+/BBB/BBB-
 
 
 
 
 
 
 
 
 
 
 
 
Single name credit default swaps
 
3,672

 
358,700

 
2.0
 
2,930

 
353,700

 
2.2
Credit default swaps referencing indices
 
769

 
817,600

 
5.0
 
(76
)
 
817,600

 
6.4
Subtotal
 
4,441

 
1,176,300

 
4.1
 
2,854

 
1,171,300

 
5.1
BB+/BB/BB-
 
 
 
 
 
 
 
 
 
 
 
 
Single name credit default swaps
 
33

 
15,000

 
0.5
 
30

 
15,000

 
0.7
Subtotal
 
33

 
15,000

 
0.5
 
30

 
15,000

 
0.7
Total
 
$
6,556

 
$
1,348,300

 
3.8
 
$
4,837

 
$
1,338,300

 
4.7
 
(1)
The rating agency designations are based on ratings from Standard and Poor’s (“S&P”).
(2)
Assumes the value of the referenced credit obligations is zero.
(3)
The weighted average years to maturity of the credit default swaps is calculated based on weighted average notional amounts.
Netting Arrangements and Credit Risk
Certain of the Company’s derivatives are subject to enforceable master netting arrangements and reported as a net asset or liability in the condensed consolidated balance sheets. The Company nets all derivatives that are subject to such arrangements.
The Company has elected to include all derivatives, except embedded derivatives, in the tables below, irrespective of whether they are subject to an enforceable master netting arrangement or a similar agreement. See Note 4 – “Investments” for information regarding the Company’s securities borrowing, lending, repurchase and repurchase/reverse repurchase programs.
The following table provides information relating to the Company’s derivative instruments as of March 31, 2019 and December 31, 2018 (dollars in thousands):
 
 
 
 
 
 
 
 
Gross Amounts Not
Offset in the Balance Sheet
 
 
 
 
Gross Amounts   
Recognized
 
Gross Amounts
Offset in the
Balance Sheet   
 
Net Amounts
Presented in the
Balance Sheet   
 
Financial
Instruments (1)    
 
Cash Collateral   
Pledged/
Received
 
Net Amount   
March 31, 2019:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative assets
 
$
206,026

 
$
(24,745
)
 
$
181,281

 
$

 
$
(205,177
)
 
$
(23,896
)
Derivative liabilities
 
52,777

 
(24,745
)
 
28,032

 
(63,992
)
 
(37,980
)
 
(73,940
)
December 31, 2018:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative assets
 
$
247,069

 
$
(18,581
)
 
$
228,488

 
$

 
$
(235,611
)
 
$
(7,123
)
Derivative liabilities
 
46,030

 
(18,581
)
 
27,449

 
(71,376
)
 
(24,080
)
 
(68,007
)
(1)
Includes initial margin posted to a central clearing partner.
The Company may be exposed to credit-related losses in the event of non-performance by counterparties to derivative financial instruments with a positive fair value. Generally, the credit exposure of the Company’s derivative contracts is limited to the fair value at the reporting date plus or minus any collateral posted or held by the Company. The Company had no credit exposure related to its derivative contracts, as of March 31, 2019 and December 31, 2018, as the net amount of collateral pledged to the Company from counterparties exceeded the fair value of the derivative contracts.
Derivatives may be exchange-traded or they may be privately negotiated contracts, which are referred to as over-the-counter (“OTC”) derivatives. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (“OTC cleared”) and others are bilateral contracts between two counterparties. The Company manages its credit risk related to OTC derivatives by entering into transactions with creditworthy counterparties, maintaining collateral arrangements and through the use of master netting agreements that provide for a single net payment to be made by one counterparty to another at each due date and upon termination. The Company is only exposed to the default of the central clearing counterparties for OTC cleared

23

Table of Contents


derivatives, and these transactions require initial and daily variation margin collateral postings. Exchange-traded derivatives are settled on a daily basis, thereby reducing the credit risk exposure in the event of non-performance by counterparties to such financial instruments.

6.    Fair Value of Assets and Liabilities
Fair Value Measurement
General accounting principles for Fair Value Measurements and Disclosures define fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. These principles also establish a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value and describes three levels of inputs that may be used to measure fair value:
Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities. The Company’s Level 1 assets and liabilities are traded in active exchange markets.
Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or market standard valuation techniques and assumptions that use significant inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the related assets or liabilities. Prices are determined using valuation methodologies such as discounted cash flow models and other similar techniques that require management’s judgment or estimation in developing inputs that are consistent with what other market participants would use when pricing similar assets and liabilities. Additionally, the Company’s embedded derivatives, all of which are associated with reinsurance treaties and longevity and mortality swaps, are classified in Level 3 since their values include significant unobservable inputs.
For a discussion of the Company’s valuation methodologies for assets and liabilities measured at fair value and the fair value hierarchy, see Note 6 in the Notes to Consolidated Financial Statements included in the Company’s 2018 Annual Report.


24

Table of Contents


Assets and Liabilities by Hierarchy Level
Assets and liabilities measured at fair value on a recurring basis as of March 31, 2019 and December 31, 2018 are summarized below (dollars in thousands):
March 31, 2019:
 
 
 
Fair Value Measurements Using:
 
 
Total    
 
Level 1        
 
Level 2    
 
Level 3    
Assets:
 
 
 
 
 
 
 
 
Fixed maturity securities – available-for-sale:
 
 
 
 
 
 
 
 
Corporate
 
$
25,077,338

 
$

 
$
23,546,583

 
$
1,530,755

Canadian government
 
4,277,864

 

 
3,670,073

 
607,791

RMBS
 
1,994,186

 

 
1,987,664

 
6,522

ABS
 
2,241,986

 

 
2,128,199

 
113,787

CMBS
 
1,431,746

 

 
1,431,725

 
21

U.S. government
 
1,567,563

 
1,464,139

 
86,215

 
17,209

State and political subdivisions
 
792,717

 

 
782,555

 
10,162

Other foreign government
 
4,355,043

 

 
4,349,977

 
5,066

Total fixed maturity securities – available-for-sale
 
41,738,443

 
1,464,139

 
37,982,991

 
2,291,313

Equity securities
 
89,865

 
49,443

 

 
40,422

Funds withheld at interest – embedded derivatives
 
107,506

 

 

 
107,506

Cash equivalents
 
855,265

 
853,927

 
1,319

 
19

Short-term investments
 
75,360

 
4,766

 
41,392

 
29,202

Other invested assets:
 
 
 
 
 
 
 
 
Derivatives:
 
 
 
 
 
 
 
 
Interest rate swaps
 
48,683

 

 
48,683

 

Foreign currency forwards
 
33,113

 

 
33,113

 

Credit default swaps
 
(6,201
)
 

 
(6,201
)
 

Equity options
 
18,676

 

 
18,676

 

Foreign currency swaps
 
38,141

 

 
38,141

 

FVO contractholder-directed unit-linked investments
 
202,848

 
201,833

 
1,015

 

Total other invested assets
 
335,260

 
201,833

 
133,427

 

Other assets - longevity swaps
 
48,869

 

 

 
48,869

Total
 
$
43,250,568

 
$
2,574,108

 
$
38,159,129

 
$
2,517,331

Liabilities:
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities – embedded derivatives
 
$
903,935

 
$

 
$

 
$
903,935

Other liabilities:
 
 
 
 
 
 
 
 
Derivatives:
 
 
 
 
 
 
 
 
Interest rate swaps
 
17,620

 

 
17,620

 

Foreign currency swaps - non-hedged
 
4,629

 

 
4,629

 

CPI swaps
 
20,505

 

 
20,505

 

Credit default swaps
 
(12,757
)
 

 
(12,757
)
 

Equity options
 
(1,476
)
 

 
(1,476
)
 

Mortality swaps
 
(489
)
 

 

 
(489
)
Total
 
$
931,967

 
$

 
$
28,521

 
$
903,446


25

Table of Contents


December 31, 2018:
 
 
 
Fair Value Measurements Using:
 
 
Total
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
 
Fixed maturity securities – available-for-sale:
 
 
 
 
 
 
 
 
Corporate
 
$
23,982,119

 
$

 
$
22,651,194

 
$
1,330,925

Canadian government
 
3,892,385

 

 
3,364,261

 
528,124

RMBS
 
1,869,221

 

 
1,862,366

 
6,855

ABS
 
2,149,204

 

 
2,053,632

 
95,572

CMBS
 
1,419,034

 

 
1,419,012

 
22

U.S. government
 
2,185,874

 
2,067,529

 
100,320

 
18,025

State and political subdivisions
 
752,194

 

 
741,992

 
10,202

Other foreign government
 
3,742,315

 

 
3,737,309

 
5,006

Total fixed maturity securities – available-for-sale
 
39,992,346

 
2,067,529

 
35,930,086

 
1,994,731

Equity securities
 
82,197

 
48,737

 

 
33,460

Funds withheld at interest – embedded derivatives
 
109,597

 

 

 
109,597

Cash equivalents
 
485,167

 
473,509

 
11,658

 

Short-term investments
 
105,991

 
4,989

 
98,774

 
2,228

Other invested assets:
 
 
 
 
 
 
 
 
Derivatives:
 
 
 
 
 
 
 
 
Interest rate swaps
 
37,976

 

 
37,976

 

Foreign currency forwards
 
50,740

 

 
50,740

 

Credit default swaps
 
4,466

 

 
4,466

 

Equity options
 
36,206

 

 
36,206

 

Foreign currency swaps
 
51,311

 

 
51,311

 

FVO contractholder-directed unit-linked investments
 
197,770

 
196,781

 
989

 

Total other invested assets
 
378,469

 
196,781

 
181,688

 

Other assets - longevity swaps
 
47,789

 

 

 
47,789

Total
 
$
41,201,556

 
$
2,791,545

 
$
36,222,206

 
$
2,187,805

Liabilities:
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities – embedded derivatives
 
$
944,865

 
$

 
$

 
$
944,865

Other liabilities:
 
 
 
 
 
 
 
 
Derivatives:
 
 
 
 
 
 
 
 
Interest rate swaps
 
18,542

 

 
18,542

 

Foreign currency swaps - non-hedged
 
4,155

 

 
4,155

 

CPI swaps
 
11,384

 

 
11,384

 

Credit default swaps
 
(371
)
 

 
(371
)
 

Equity options
 
(6,630
)
 

 
(6,630
)
 

Mortality swaps
 
369

 

 

 
369

Total
 
$
972,314

 
$

 
$
27,080

 
$
945,234

Transfers between Levels 1 and 2
Transfers between Levels 1 and 2 are made to reflect changes in observability of inputs and market activity. The Company recognizes transfers of assets and liabilities into and out of levels within the fair value hierarchy at the beginning of the quarter in which the actual event or change in circumstances that caused the transfer occurs. There were no transfers between Level 1 and Level 2 during the three months ended March 31, 2019 or 2018.

26

Table of Contents


Quantitative Information Regarding Internally - Priced Assets and Liabilities
The following table presents quantitative information about significant unobservable inputs used in Level 3 fair value measurements that are developed internally by the Company as of March 31, 2019 and December 31, 2018 (dollars in thousands):
 
 
Estimated Fair Value      
 
Valuation Technique
 
Unobservable Inputs
 
Range (Weighted Average) 
March 31, 2019
 
December 31, 2018
 
 
 
March 31, 2019
 
December 31, 2018
Assets:
 
 
 
 
 
 
 
 
 
 
 
Corporate
$740,698
 
$642,647
 
Market comparable securities
 
Liquidity premium
 
0-5% (1%)

 
0-5%  (1%)

 
 
 
 
 
 
 
EBITDA Multiple
 
5.9x

 
5.9x-7.5x (6.5x)

ABS
81,417

 
77,842

 
Market comparable securities
 
Liquidity premium
 
0-1% (1%)

 
0-1%  (1%)

U.S. government
17,209

 
18,025

 
Market comparable securities
 
Liquidity premium
 
0-1% (1%)

 
0-1%  (1%)

Other foreign government
5,066

 
5,006

 
Market comparable
securities
 
Liquidity premium
 
1
%
 
1
%
Equity securities
30,294

 
25,007

 
Market comparable securities
 
Liquidity premium
 
4
%
 
4
%
 
 
 
 
 
 
 
EBITDA Multiple
 
6.9x-12.3x (8.2x)

 
6.9x-12.3x (7.9x)

Funds withheld at interest- embedded derivatives
107,506

 
109,597

 
Total return swap
 
Mortality
 
0-100%  (2%)

 
0-100%  (2%)

 
 
 
 
 
 
 
Lapse
 
0-35%  (11%)

 
0-35%  (10%)

 
 
 
 
 
 
 
Withdrawal
 
0-5%  (3%)

 
0-5%  (3%)

 
 
 
 
 
 
 
CVA
 
0-5%  (1%)

 
0-5%  (1%)

 
 
 
 
 
 
 
Crediting rate
 
2-4%  (2%)

 
2-4%  (2%)

Longevity swaps
48,869

 
47,789

 
Discounted cash flow
 
Mortality
 
0-100%  (2%)

 
0-100%  (2%)

 
 
 
 
 
 
 
Mortality improvement
 
(10%)-10%   (3%)

 
(10%)-10%  (3%)

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities- embedded derivatives- indexed annuities
754,171

 
776,940

 
Discounted cash flow
 
Mortality
 
0-100%  (2%)

 
0-100% (2%)

 
 
 
 
 
 
 
Lapse
 
0-35%  (11%)

 
0-35% (10%)

 
 
 
 
 
 
 
Withdrawal
 
0-5%  (3%)

 
0-5% (3%)

 
 
 
 
 
 
 
Option budget projection
 
2-4%  (2%)

 
2-4% (2%)

Interest sensitive contract liabilities- embedded derivatives- variable annuities
149,764

 
167,925

 
Discounted cash 
flow
 
Mortality
 
0-100% (1%)

 
0-100% (1%)

 
 
 
 
 
 
 
Lapse
 
0-25% (5%)

 
0-25% (5%)

 
 
 
 
 
 
 
Withdrawal
 
0-7% (4%)

 
0-7% (5%)

 
 
 
 
 
 
 
CVA
 
0-5% (1%)

 
0-5% (1%)

 
 
 
 
 
 
 
Long-term volatility
 
0-27% (13%)

 
0-27% (13%)

Mortality swaps
(489
)
 
369

 
Discounted cash flow
 
Mortality
 
0-100%  (1%)

 
0-100%  (1%)



27

Table of Contents


Changes in Level 3 Assets and Liabilities
Assets and liabilities transferred into Level 3 are due to a lack of observable market transactions and price information. Transfers out of Level 3 are primarily the result of the Company obtaining observable pricing information or a third party pricing quotation that appropriately reflects the fair value of those assets and liabilities. In 2018, the Company transferred equity securities with a fair value of approximately $38.9 million into Level 3 as a result of the adoption of the new accounting guidance for the recognition and measurement of equity securities (see “New Accounting Pronouncements – Financial Instruments – Recognition and Measurement” in Note 2 – “Significant Accounting Policies and Pronouncements” in the Notes to Consolidated Financial Statements included in the Company’s 2018 Annual Report).
For further information on the Company’s valuation processes, see Note 6 in the Notes to Consolidated Financial Statements included in the Company’s 2018 Annual Report.
The reconciliations for all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) are as follows (dollars in thousands):
For the three months ended March 31, 2019:
 
Fixed maturity securities - available-for-sale
 
 
Corporate
 
Canadian government
 
RMBS
 
ABS
Fair value, beginning of period
 
$
1,330,925

 
$
528,124

 
$
6,855

 
$
95,572

Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
133

 
3,493

 
2

 
17

Included in other comprehensive income
 
19,404

 
76,174

 
1

 
975

Purchases(1)
 
214,441

 

 

 
31,322

Sales(1)
 
(10,712
)
 

 

 

Settlements(1)
 
(23,436
)
 

 
(336
)
 
(14,099
)
Fair value, end of period
 
$
1,530,755

 
$
607,791

 
$
6,522

 
$
113,787

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$
166

 
$
3,493

 
$
2

 
$
17

For the three months ended March 31, 2019 (continued):
 
Fixed maturity securities - available-for-sale
 
 
 
 
CMBS
 
U.S. government
 
State
and political
subdivisions
 
Other foreign government
 
Equity securities
Fair value, beginning of period
 
$
22

 
$
18,025

 
$
10,202

 
$
5,006

 
33,460

Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 

 
(89
)
 
5

 

 

Investment related gains (losses), net
 

 

 

 

 
3,762

Included in other comprehensive income
 

 
267

 
(7
)
 
60

 

Purchases(1)
 

 
84

 

 

 
3,200

Settlements(1)
 
(1
)
 
(1,078
)
 
(38
)
 

 

Fair value, end of period
 
$
21

 
$
17,209

 
$
10,162

 
$
5,066

 
$
40,422

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$

 
$
(89
)
 
$
5

 
$

 
$

Investment related gains (losses), net
 

 

 

 

 
3,762


 

28

Table of Contents


For the three months ended March 31, 2019 (continued):
 
Funds withheld
at interest-
embedded
derivatives
 
Cash equivalents
 
Short-term investments
 
Other assets - longevity swaps
 
Interest sensitive contract liabilities embedded derivatives
 
Other liabilities - mortality swaps
Fair value, beginning of period
 
$
109,597

 
$

 
$
2,228

 
$
47,789

 
$
(944,865
)
 
$
(369
)
Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 

 

 
32

 

 

 

Investment related gains (losses), net
 
(2,091
)
 

 

 

 
18,161

 

Interest credited
 

 

 

 

 
3,070

 

Included in other comprehensive income
 

 

 
199

 
(1,063
)
 

 

Other revenues
 

 

 

 
2,143

 

 
858

Purchases(1)
 

 
19

 
26,743

 

 
1,398

 

Settlements(1)
 

 

 

 

 
18,301

 

Fair value, end of period

$
107,506

 
$
19

 
$
29,202

 
$
48,869

 
$
(903,935
)
 
$
489

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$

 
$

 
$
32

 
$

 
$

 
$

Investment related gains (losses), net
 
(2,091
)
 

 

 

 
16,766

 

Other revenues
 

 

 

 
2,143

 

 
858

Interest credited
 

 

 

 

 
(15,231
)
 

For the three months ended March 31, 2018:
 
Fixed maturity securities - available-for-sale
 
 
Corporate
 
Canadian government
 
RMBS
 
ABS
Fair value, beginning of period
 
$
1,337,272

 
$
593,942

 
$
107,882

 
$
123,474

Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
(361
)
 
3,444

 
(92
)
 
106

Investment related gains (losses), net
 

 

 

 
2

Included in other comprehensive income
 
(32,852
)
 
(24,639
)
 
(1,110
)
 
853

Purchases(1)
 
100,170

 

 
20,916

 
11,000

Sales(1)
 
(6,180
)
 

 

 

Settlements(1)
 
(75,146
)
 

 
(2,963
)
 
(2,739
)
Transfers into Level 3
 
7,166

 

 

 

Transfers out of Level 3
 
(30,805
)
 

 
(4,019
)
 
(1,990
)
Fair value, end of period
 
$
1,299,264

 
$
572,747

 
$
120,614

 
$
130,706

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$
(361
)
 
$
3,444

 
$
(92
)
 
$
106


29

Table of Contents


For the three months ended March 31, 2018 (continued):
 
Fixed maturity securities - available-for-sale
 
 
CMBS
 
U.S. government
 
State
and political
subdivisions
 
Other foreign government
Fair value, beginning of period
 
$
3,234

 
$
22,511

 
$
41,203

 
$
5,092

Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 

 
(110
)
 
8

 

Included in other comprehensive income
 
(47
)
 
(340
)
 
700

 
(88
)
Purchases(1)
 

 
96

 

 

Settlements(1)
 
(1
)
 
(1,104
)
 
(35
)
 

Transfers out of Level 3
 
(1,302
)
 

 

 

Fair value, end of period
 
$
1,884

 
$
21,053

 
$
41,876

 
$
5,004

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$

 
$
(110
)
 
$
8

 
$


 
For the three months ended March 31, 2018 (continued):
 
Equity securities
 
Funds withheld
at interest-
embedded
derivatives
 
Short-term investments
 
Other assets - longevity swaps
 
Interest sensitive contract liabilities embedded derivatives
 
Other liabilities - mortality swaps
Fair value, beginning of period
 
$

 
$
122,194

 
$
3,096

 
$
40,659

 
$
(1,014,229
)
 
$
(1,683
)
Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment related gains (losses), net
 
(2,677
)
 
13,611

 

 

 
14,785

 

Interest credited
 

 

 

 

 
25,351

 

Included in other comprehensive income
 

 

 
(25
)
 
1,085

 

 

Other revenues
 

 

 

 
2,267

 

 

Purchases(1)
 

 

 
146

 

 
(8,508
)
 

Sales(1)
 
(28
)
 

 

 

 

 

Settlements(1)
 
(48
)
 

 

 

 
17,807

 

Transfers into Level 3
 
38,905

 

 

 

 

 

Fair value, end of period
 
$
36,152

 
$
135,805

 
$
3,217

 
$
44,011

 
$
(964,794
)
 
$
(1,683
)
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment related gains (losses), net
 
$
(2,705
)
 
$
13,611

 
$

 
$

 
$
12,901

 
$

Other revenues
 

 

 

 
2,267

 

 

Interest credited
 

 

 

 

 
7,544

 


(1)
The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.
Nonrecurring Fair Value Measurements
During the three months ended March 31, 2019 and March 31, 2018, the Company did not have any adjustments to its financial instruments measured at fair value on a nonrecurring basis that are still held at the reporting date.

30

Table of Contents


Fair Value of Financial Instruments
The Company is required by general accounting principles for Fair Value Measurements and Disclosures to disclose the fair value of certain financial instruments including those that are not carried at fair value. The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments, which were not measured at fair value on a recurring basis, as of March 31, 2019 and December 31, 2018 (dollars in thousands). For additional information regarding the methods and significant assumptions used by the Company to estimate these fair values, see Note 6 in the Notes to Consolidated Financial Statements included in the Company’s 2018 Annual Report. This table excludes any payables or receivables for collateral under repurchase agreements and other transactions. The estimated fair value of the excluded amount approximates carrying value as they equal the amount of cash collateral received/paid.
March 31, 2019:
 
Carrying Value (1)
 
Estimated 
Fair Value
 
Fair Value Measurement Using:
Level 1
 
Level 2
 
Level 3
 
NAV
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage loans on real estate
 
$
5,117,545

 
$
5,210,513

 
$

 
$

 
$
5,210,513

 
$

Policy loans
 
1,312,349

 
1,312,349

 

 
1,312,349

 

 

Funds withheld at interest
 
5,619,039

 
5,823,245

 

 

 
5,823,245

 

Cash and cash equivalents
 
1,165,131

 
1,165,131

 
1,165,131

 

 

 

Short-term investments
 
43,855

 
43,855

 
43,855

 

 

 

Other invested assets
 
1,061,220

 
1,060,931

 
5,176

 
83,529

 
603,835

 
368,391

Accrued investment income
 
442,956

 
442,956

 

 
442,956

 

 

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Interest-sensitive contract liabilities
 
$
14,543,332

 
$
14,790,369

 
$

 
$

 
$
14,790,369

 
$

Long-term debt
 
2,787,717

 
2,915,623

 

 

 
2,915,623

 

Collateral finance and securitization notes
 
656,174

 
601,680

 

 

 
601,680

 

 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2018:
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage loans on real estate
 
$
4,966,298

 
$
4,917,416

 
$

 
$

 
$
4,917,416

 
$

Policy loans
 
1,344,980

 
1,344,980

 

 
1,344,980

 

 

Funds withheld at interest
 
5,655,055

 
5,802,518

 

 

 
5,802,518

 

Cash and cash equivalents
 
1,404,566

 
1,404,566

 
1,404,566

 

 

 

Short-term investments
 
36,607

 
36,607

 
36,607

 

 

 

Other invested assets
 
945,731

 
941,449

 
4,640

 
83,203

 
477,214

 
376,392

Accrued investment income
 
427,893

 
427,893

 

 
427,893

 

 

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Interest-sensitive contract liabilities
 
$
14,547,436

 
$
14,611,011

 
$

 
$

 
$
14,611,011

 
$

Long-term debt
 
2,787,873

 
2,752,047

 

 

 
2,752,047

 

Collateral finance and securitization notes
 
681,961

 
626,731

 

 

 
626,731

 

 
(1)
Carrying values presented herein may differ from those in the Company’s condensed consolidated balance sheets because certain items within the respective financial statement captions may be measured at fair value on a recurring basis.

7.
Segment Information
The accounting policies of the segments are the same as those described in the Significant Accounting Policies and Pronouncements in Note 2 of the consolidated financial statements accompanying the 2018 Annual Report. The Company measures segment performance primarily based on profit or loss from operations before income taxes. There are no intersegment reinsurance transactions and the Company does not have any material long-lived assets.
The Company allocates capital to its segments based on an internally developed economic capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. The economic capital model considers the unique and specific nature of the risks inherent in the Company’s businesses. As a result of the economic capital allocation process, a portion of investment income is attributed to the segments based on the level of allocated capital. In addition, the segments are charged for excess capital utilized above the allocated economic capital basis. This charge is included in policy acquisition costs and other insurance expenses.

31

Table of Contents


The Company has geographic-based and business-based operational segments. Geographic-based operations are further segmented into traditional and financial solutions businesses. Information related to revenues, income (loss) before income taxes and total assets of the Company for each reportable segment are summarized below (dollars in thousands):
 
Three months ended March 31,
Revenues:
2019
 
2018
U.S. and Latin America:
 
 
 
Traditional
$
1,540,666

 
$
1,489,694

Financial Solutions
254,660

 
213,352

Total
1,795,326

 
1,703,046

Canada:
 
 
 
Traditional
312,333

 
302,319

Financial Solutions
23,574

 
12,777

Total
335,907

 
315,096

Europe, Middle East and Africa:
 
 
 
Traditional
384,006

 
393,782

Financial Solutions
109,421

 
88,143

Total
493,427

 
481,925

Asia Pacific:
 
 
 
Traditional
673,172

 
614,539

Financial Solutions
54,528

 
19,846

Total
727,700

 
634,385

Corporate and Other
67,671

 
39,255

Total
$
3,420,031

 
$
3,173,707

 
 
Three months ended March 31,
Income (loss) before income taxes:
 
2019
 
2018
U.S. and Latin America:
 
 
 
 
Traditional
 
$
11,654

 
$
2,892

Financial Solutions
 
83,277

 
67,421

Total
 
94,931

 
70,313

Canada:
 
 
 
 
Traditional
 
50,279

 
23,707

Financial Solutions
 
1,348

 
3,191

Total
 
51,627

 
26,898

Europe, Middle East and Africa:
 
 
 
 
Traditional
 
15,424

 
15,421

Financial Solutions
 
38,390

 
39,164

Total
 
53,814

 
54,585

Asia Pacific:
 
 
 
 
Traditional
 
36,624

 
22,887

Financial Solutions
 
6,083

 
4,021

Total
 
42,707

 
26,908

Corporate and Other
 
(26,515
)
 
(40,779
)
Total
 
$
216,564

 
$
137,925

Assets:
 
March 31, 2019
 
December 31, 2018
U.S. and Latin America:
 
 
 
 
Traditional
 
$
18,820,270

 
$
19,235,781

Financial Solutions
 
20,308,486

 
19,870,388

Total
 
39,128,756

 
39,106,169

Canada:
 
 
 
 
Traditional
 
3,579,658

 
4,200,792

Financial Solutions
 
57,549

 
154,000

Total
 
3,637,207

 
4,354,792

Europe, Middle East and Africa:
 
 
 
 
Traditional
 
3,797,482

 
3,643,174

Financial Solutions
 
4,968,853

 
4,737,529

Total
 
8,766,335

 
8,380,703

Asia Pacific:
 
 
 
 
Traditional
 
6,043,694

 
5,680,978

Financial Solutions
 
1,530,360

 
1,180,745

Total
 
7,574,054

 
6,861,723

Corporate and Other
 
7,586,129

 
5,831,858

Total
 
$
66,692,481

 
$
64,535,245


32

Table of Contents


8.
Commitments, Contingencies and Guarantees
Commitments
Funding of Investments
The Company’s commitments to fund investments as of March 31, 2019 and December 31, 2018 are presented in the following table (dollars in thousands):
 
March 31, 2019
 
December 31, 2018
Limited partnership interests and joint ventures
$
579,647

 
$
523,903

Commercial mortgage loans
147,898

 
22,605

Bank loans and private placements
77,854

 
137,076

Equity release mortgages
215,305

 
264,858

The Company anticipates that the majority of its current commitments will be invested over the next five years; however, these commitments could become due any time at the request of the counterparties. Bank loans and private placements are included in fixed maturity securities available-for-sale.
Contingencies
Litigation
The Company is subject to litigation in the normal course of its business. The Company currently has no material litigation. A legal reserve is established when the Company is notified of an arbitration demand or litigation or is notified that an arbitration demand or litigation is imminent, it is probable that the Company will incur a loss as a result and the amount of the probable loss is reasonably capable of being estimated.
Other Contingencies
The Company indemnifies its directors and officers as provided in its charters and by-laws. Since this indemnity generally is not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount due under this indemnity in the future.
Guarantees
Statutory Reserve Support
RGA, through wholly-owned subsidiaries, has committed to provide statutory reserve support to third parties, in exchange for a fee, by funding loans if certain defined events occur. Such statutory reserves are required under the U.S. Valuation of Life Policies Model Regulation (commonly referred to as Regulation XXX for term life insurance policies and Regulation A-XXX for universal life secondary guarantees). The third parties have recourse to RGA should the subsidiary fail to provide the required funding, however, as of March 31, 2019, the Company does not believe that it will be required to provide any funding under these commitments as the occurrence of the defined events is considered remote. The following table presents the maximum potential obligation for these commitments as of March 31, 2019 (dollars in millions):
Commitment Period
Maximum Potential Obligation
2023
$
500.0

2033
450.0

2034
2,000.0

2035
1,314.2

2036
2,658.0

2037
5,750.0

2038
1,800.0


33

Table of Contents


Other Guarantees
RGA has issued guarantees to third parties on behalf of its subsidiaries for the payment of amounts due under certain securities borrowing and repurchase arrangements, financing arrangements and office lease obligations, whereby, if a subsidiary fails to meet an obligation, RGA or one of its other subsidiaries will make a payment to fulfill the obligation. Additionally, in limited circumstances, treaty guarantees are granted to ceding companies in order to provide them additional security, particularly in cases where RGA’s subsidiary is relatively new, unrated, or not of a significant size, relative to the ceding company. Liabilities supported by the treaty guarantees, before consideration of any legally offsetting amounts due from the guaranteed party are reflected on the Company’s condensed consolidated balance sheets in future policy benefits. Potential guaranteed amounts of future payments will vary depending on production levels and underwriting results. Guarantees related to securities borrowing and repurchase arrangements provide additional security to third parties should a subsidiary fail to provide securities when due. RGA’s guarantees issued as of March 31, 2019 and December 31, 2018 are reflected in the following table (dollars in thousands):
 
March 31, 2019
 
December 31, 2018
Treaty guarantees
$
1,481,172

 
$
1,392,352

Treaty guarantees, net of assets in trust
1,381,152

 
1,291,445

Securities borrowing and repurchase arrangements
272,365

 
269,980

Financing arrangements
57,801

 
61,273

Lease obligations
401

 
392

9.
Income Tax
The provision for income tax expense differed from the amounts computed by applying the U.S. federal income tax statutory rate of 21% to pre-tax income as a result of the following for the three months ended March 31, 2019 and 2018, respectively (dollars in thousands):
 
 
Three months ended March 31,
 
 
2019
 
2018
Tax provision at U.S. statutory rate
 
$
45,478

 
$
28,964

Increase (decrease) in income taxes resulting from:
 
 
 
 
U.S. Tax Reform
 

 
775

Foreign tax rate differing from U.S. tax rate
 
664

 
1,432

Differences in tax bases in foreign jurisdictions
 
(15,078
)
 
(5,760
)
Deferred tax valuation allowance
 
18,544

 
7,947

Amounts related to tax audit contingencies
 
560

 
835

Corporate rate changes
 
(1,764
)
 
111

Subpart F
 
165

 
658

Foreign tax credits
 

 
(572
)
Global intangible low-taxed income, net of credit
 

 
4,409

Equity compensation excess benefit
 
(1,461
)
 
(1,114
)
Other, net
 
(51
)
 
10

Total provision for income taxes
 
$
47,057

 
$
37,695

Effective tax rate
 
21.7
%
 
27.3
%
The effective tax rate for the three months ended March 31, 2019 and 2018 was higher than the U.S. Statutory tax rate of 21% primarily as a result of income in non-U.S. jurisdictions with tax rates greater than the U.S. and losses in foreign jurisdictions for which the company established a valuation allowance, which was partially offset with tax benefits related to bases differences in non-U.S. jurisdictions. The effective tax for the three months ended March 31, 2018 was further increased due to the inclusion of U.S. tax related to global intangible low-taxed income (“GILTI”).

34

Table of Contents


10.    Employee Benefit Plans
The components of net periodic benefit cost, included in other operating expenses on the condensed consolidated statements of income, for the three months ended March 31, 2019 and 2018 were as follows (dollars in thousands):
 
 
Pension Benefits
 
Other Benefits
 
 
Three months ended March 31,
 
Three months ended March 31,
 
 
2019
 
2018
 
2019
 
2018
Service cost
 
$
3,138

 
$
2,654

 
$
757

 
$
636

Interest cost
 
1,386

 
1,330

 
580

 
530

Expected return on plan assets
 
(1,884
)
 
(1,554
)
 

 

Amortization of prior service cost (credit)
 
60

 
83

 
(329
)
 
(329
)
Amortization of prior actuarial losses
 
911

 
1,094

 
644

 
498

Net periodic benefit cost
 
$
3,611

 
$
3,607

 
$
1,652

 
$
1,335

 
11.
Reinsurance
Retrocession reinsurance treaties do not relieve the Company from its obligations to direct writing companies. Failure of retrocessionaires to honor their obligations could result in losses to the Company. Consequently, allowances would be established for amounts deemed uncollectible. At March 31, 2019 and December 31, 2018, no allowances were deemed necessary. The Company regularly evaluates the financial condition of the insurance companies from which it assumes and to which it cedes reinsurance.
Retrocessions are arranged through the Company’s retrocession pools for amounts in excess of the Company’s retention limit. As of March 31, 2019, all rated retrocession pool participants followed by the A.M. Best Company were rated “A- (excellent)” or better. The Company verifies retrocession pool participants’ ratings on a quarterly basis. For a majority of the retrocessionaires that were not rated, security in the form of letters of credit or trust assets has been posted. In addition, the Company performs annual financial reviews of its retrocessionaires to evaluate financial stability and performance. In addition to its third party retrocessionaires, various RGA reinsurance subsidiaries retrocede amounts in excess of their retention to affiliated subsidiaries.
The following table presents information for the Company’s reinsurance ceded receivable assets, including the respective amount and A.M. Best rating for each reinsurer representing in excess of five percent of the total as of March 31, 2019 or December 31, 2018 (dollars in thousands):
 
 
 
 
March 31, 2019
 
December 31, 2018
Reinsurer
 
A.M. Best Rating
 
Amount
 
% of Total
 
Amount
 
% of Total
Reinsurer A
 
A+
 
$
324,370

 
39.8
%
 
$
303,036

 
40.0
%
Reinsurer B
 
A+
 
199,748

 
24.5

 
193,324

 
25.5

Reinsurer C
 
A
 
71,367

 
8.8

 
69,885

 
9.2

Reinsurer D
 
A++
 
50,244

 
6.2

 
36,600

 
4.8

Reinsurer E
 
A+
 
41,362

 
5.1

 
40,004

 
5.3

Other reinsurers
 
 
 
127,715

 
15.6

 
114,723

 
15.2

Total
 
 
 
$
814,806

 
100.0
%
 
$
757,572

 
100.0
%
Included in the total reinsurance ceded receivables balance were $232.0 million and $242.8 million of claims recoverable, of which $6.7 million and $17.4 million were in excess of 90 days past due, as of March 31, 2019 and December 31, 2018, respectively.

35

Table of Contents


12.
Policy Claims and Benefits
Rollforward of Claims and Claim Adjustment Expenses
The liability for unpaid claims is reported in future policy benefits and other policy-related balances within the Company’s consolidated balance sheet. Activity associated with unpaid claims is summarized below (dollars in thousands):
 
 
Three months ended March 31,
 
 
2019
 
2018
Balance at beginning of year
 
$
6,584,668

 
$
5,896,469

Less: reinsurance recoverable
 
(432,582
)
 
(455,547
)
Net balance at beginning of year
 
6,152,086

 
5,440,922

Incurred:
 
 
 
 
Current year
 
2,807,937

 
2,663,116

Prior years
 
31,447

 
6,255

Total incurred
 
2,839,384

 
2,669,371

Payments:
 
 
 
 
Current year
 
(186,601
)
 
(180,802
)
Prior years
 
(2,387,312
)
 
(2,111,275
)
Total payments
 
(2,573,913
)
 
(2,292,077
)
Other changes:
 
 
 
 
Interest accretion
 
6,556

 
6,115

Foreign exchange adjustments
 
9,630

 
26,676

Total other changes
 
16,186

 
32,791

 
 
 
 
 
Net balance at end the period
 
6,433,743

 
5,851,007

Plus: reinsurance recoverable
 
499,562

 
469,419

Balance at end of the period
 
$
6,933,305

 
$
6,320,426

Incurred claims related to prior years reflected in the table above, resulted in part from developed claims for prior years being different than were anticipated when the liabilities for unpaid claims were originally estimated.  These trends have been considered in establishing the current year liability for unpaid claims.

13.
New Accounting Standards
Changes to the general accounting principles are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates to the FASB Accounting Standards Codification™. Accounting standards updates not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company’s condensed consolidated financial statements.

36

Table of Contents


Description
Date of Adoption
Effect on the financial statements or other significant matters
Standards adopted:
 
 
Financial Instruments - Recognition and Measurement
This guidance requires equity investments that are not accounted for under the equity method of accounting to be measured at fair value with changes recognized in net income and also updates certain presentation and disclosure requirements.

January 1, 2018

This guidance required a cumulative-effect adjustment for certain items upon adoption. The adoption of the new guidance was not material to the Company's financial position.
Compensation - Retirement Benefits - Defined Benefit Plans - General
This guidance is part of the FASB’s disclosure framework project and eliminates certain disclosure requirements for defined benefit pension and other postretirement plans. Early adoption is permitted.

December 31, 2018

This guidance was applied retrospectively to all periods presented in the year of adoption. The adoption of the new standard was not material to the Company’s financial position.
Leases
This new standard, based on the principle that entities should recognize assets and liabilities arising from leases, does not significantly change the lessees’ recognition, measurement and presentation of expenses and cash flows from the previous accounting standard. Leases are classified as finance or operating. The new standard’s primary change is the requirement for entities to recognize a lease liability for payments and a right of use asset representing the right to use the leased asset during the term of operating lease arrangements. Lessees are permitted to make an accounting policy election to not recognize the asset and liability for leases with a term of twelve months or less. Lessors’ accounting is largely unchanged from the previous accounting standard. In addition, the new standard expands the disclosure requirements of lease arrangements. Early adoption is permitted.

January 1, 2019

This guidance was adopted by applying the optional transition method. The adoption of the standard did not have a material impact on the Company’s results of operations or financial position. The adoption of the updated guidance resulted in the Company recognizing a right-to-use asset and lease liability of $55.2 million included in other assets and other liabilities, respectively, in the condensed consolidated balance sheets.
Derivatives and Hedging
This updated guidance improves the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements and make certain targeted improvements to simplify the application of the hedge accounting in current GAAP related to the assessment of hedge effectiveness. Early adoption is permitted.

January 1, 2019

This guidance was adopted by applying a modified retrospective approach to existing hedging relationships as of the date of adoption. The adoption of the new standard did not have a material impact on the Company’s results of operations or financial position. Upon adoption of the standard, the Company recorded an immaterial adjustment to retained earnings as of the beginning of the first reporting period in which the guidance was effective and modified some disclosures.

37

Table of Contents


Description
Date of Adoption
Effect on the financial statements or other significant matters
Standards not yet adopted:
 
 
Financial Services - Insurance
This guidance significantly changes how insurers account for long-duration insurance contracts. The new guidance also significantly expands the disclosure requirements of long-duration insurance contracts. Below are the most significant areas of change:

Cash flow assumptions for measuring liability for future policy benefits The new guidance requires insurers to review, and if necessary, update the cash flow assumptions used to measure liabilities for future policy benefits periodically. The change in the liability estimate as a result of updating cash flow assumptions will be recognized in net income.



Discount rate assumption for measuring liability for future policy benefits The new guidance requires insurers to update the discount rate assumption used to measure liabilities for future policy benefits at each reporting period, and the discount rate utilized must be based on an upper-medium grade fixed income instrument yield. The change in the liability estimate as a result of updating the discount rate assumption will be recognized in other comprehensive income.

Market risk benefits The new guidance created a new category of benefit features called market risk benefits that will be measured at fair value with changes in fair value attributable to a change in the instrument-specific credit risk recognized in other comprehensive income.


Amortization of deferred acquisition costs (“DAC”) and other balances The new guidance requires DAC and other balances to be amortized on a constant level basis over the expected term of the related contracts.

January 1, 2021

See each significant area of change below for the method of adoption and impact to the Company’s results of operations and financial position.


Cash flow assumptions for measuring liability for future policy benefits The Company will likely adopt this guidance on a modified retrospective basis as of the earliest period presented in the year of adoption. The Company is currently evaluating the impact of this amendment on its results of operations and financial position but anticipates the updated guidance will likely have a material impact.

Discount rate assumption for measuring liability for future policy benefits The Company will likely adopt this guidance on a modified retrospective basis as of the earliest period presented in the year of adoption. The Company is currently evaluating the impact of this amendment on its results of operations and financial position but anticipates the updated guidance will likely have a material impact.

Market risk benefits The Company will adopt this guidance on a retrospective basis as of the earliest period presented in the year of adoption. The Company is currently evaluating the impact of this amendment on its results of operations and financial position but anticipates the guidance will likely have a material impact.

Amortization of deferred acquisition costs (“DAC”) and other balances The Company will likely adopt this guidance on a modified retrospective basis as of the earliest period presented in the year of adoption. The Company is currently evaluating the impact of this amendment on its results of operations and financial position but anticipates the updated guidance will likely have a material impact.
Financial Instruments - Credit Losses
This guidance adds to U.S. GAAP an impairment model, known as current expected credit loss (“CECL”) model that is based on expected losses rather than incurred losses. For traditional and other receivables, held-to-maturity debt securities, loans and other instruments entities will be required to use the new forward-looking “expected loss” model that generally will result in earlier recognition of allowance for losses. For available-for-sale debt securities with unrealized losses, entities will measure credit losses similar to what they do today, except the losses will be recognized as allowances rather than reduction to the amortized cost of the securities. Early adoption is permitted.

January 1, 2020

This guidance will be adopted through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (that is, a modified-retrospective approach). The Company is currently evaluating the impact of this amendment on its results of operations and financial position.
Fair Value Measurement
This guidance is part of the FASB’s disclosure framework project and eliminates certain disclosure requirements for fair value measurement, requires entities to disclose new information and modifies existing disclosure requirements. Early adoption is permitted.

January 1, 2020

Certain disclosure changes in the new guidance will be applied prospectively in the year of adoption. The remaining changes in the new guidance will be applied retrospectively to all periods presented in the year of adoption. The Company is currently evaluating the impact of this amendment on its results of operations and financial position.


38

Table of Contents


ITEM 2.        MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Cautionary Note Regarding Forward-Looking Statements
This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including, among others, statements relating to projections of the strategies, earnings, revenues, income or loss, ratios, future financial performance, and growth potential of the Company. The words “intend,” “expect,” “project,” “estimate,” “predict,” “anticipate,” “should,” “believe,” and other similar expressions also are intended to identify forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results, performance, and achievements could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.
Numerous important factors could cause actual results and events to differ materially from those expressed or implied by forward-looking statements including, without limitation, (1) adverse capital and credit market conditions and their impact on the Company’s liquidity, access to capital and cost of capital, (2) the impairment of other financial institutions and its effect on the Company’s business, (3) requirements to post collateral or make payments due to declines in market value of assets subject to the Company’s collateral arrangements, (4) the fact that the determination of allowances and impairments taken on the Company’s investments is highly subjective, (5) adverse changes in mortality, morbidity, lapsation or claims experience, (6) changes in the Company’s financial strength and credit ratings and the effect of such changes on the Company’s future results of operations and financial condition, (7) inadequate risk analysis and underwriting, (8) general economic conditions or a prolonged economic downturn affecting the demand for insurance and reinsurance in the Company’s current and planned markets, (9) the availability and cost of collateral necessary for regulatory reserves and capital, (10) market or economic conditions that adversely affect the value of the Company’s investment securities or result in the impairment of all or a portion of the value of certain of the Company’s investment securities, that in turn could affect regulatory capital, (11) market or economic conditions that adversely affect the Company’s ability to make timely sales of investment securities, (12) risks inherent in the Company’s risk management and investment strategy, including changes in investment portfolio yields due to interest rate or credit quality changes, (13) fluctuations in U.S. or foreign currency exchange rates, interest rates, or securities and real estate markets, (14) adverse litigation or arbitration results, (15) the adequacy of reserves, resources and accurate information relating to settlements, awards and terminated and discontinued lines of business, (16) the stability of and actions by governments and economies in the markets in which the Company operates, including ongoing uncertainties regarding the amount of U.S. sovereign debt and the credit ratings thereof, (17) competitive factors and competitors’ responses to the Company’s initiatives, (18) the success of the Company’s clients, (19) successful execution of the Company’s entry into new markets, (20) successful development and introduction of new products and distribution opportunities, (21) the Company’s ability to successfully integrate acquired blocks of business and entities, (22) action by regulators who have authority over the Company’s reinsurance operations in the jurisdictions in which it operates, (23) the Company’s dependence on third parties, including those insurance companies and reinsurers to which the Company cedes some reinsurance, third-party investment managers and others, (24) the threat of natural disasters, catastrophes, terrorist attacks, epidemics or pandemics anywhere in the world where the Company or its clients do business, (25) interruption or failure of the Company’s telecommunication, information technology or other operational systems, or the Company’s failure to maintain adequate security to protect the confidentiality or privacy of personal or sensitive data stored on such systems, (26) changes in laws, regulations, and accounting standards applicable to the Company, its subsidiaries, or its business, (27) the benefits or burdens associated with the Tax Cuts and Jobs Act of 2017 may be different than expected, (28) the effect of the Company’s status as an insurance holding company and regulatory restrictions on its ability to pay principal of and interest on its debt obligations, and (29) other risks and uncertainties described in this document and in the Company’s other filings with the Securities and Exchange Commission (“SEC”).
Forward-looking statements should be evaluated together with the many risks and uncertainties that affect the Company’s business, including those mentioned in this document and described in the periodic reports the Company files with the SEC. These forward-looking statements speak only as of the date on which they are made. The Company does not undertake any obligations to update these forward-looking statements, even though the Company’s situation may change in the future. For a discussion of these risks and uncertainties that could cause actual results to differ materially from those contained in the forward-looking statements, you are advised to see Item 1A – “Risk Factors” in the 2018 Annual Report.
Overview
The Company is among the leading global providers of life reinsurance and financial solutions, with $3.4 trillion of life reinsurance in force and assets of $66.7 billion as of March 31, 2019. Traditional reinsurance includes individual and group life and health, disability, and critical illness reinsurance. Financial solutions includes longevity reinsurance, asset-intensive reinsurance, financial reinsurance and stable value products. The Company derives revenues primarily from renewal premiums from existing reinsurance treaties, new business premiums from existing or new reinsurance treaties, fee income from financial solutions business and income earned on invested assets.

39

Table of Contents


Historically, the Company’s primary business has been traditional life reinsurance, which involves reinsuring life insurance policies that are often in force for the remaining lifetime of the underlying individuals insured, with premiums earned typically over a period of 10 to 30 years. Each year, however, a portion of the business under existing treaties terminates due to, among other things, lapses or voluntary surrenders of underlying policies, deaths of insureds, and the exercise of recapture options by ceding companies. The Company has expanded its financial solutions business, including significant asset-intensive and longevity risk transactions, which allow its clients to take advantage of growth opportunities and manage their capital, longevity and investment risk.
The Company’s long-term profitability largely depends on the volume and amount of death- and health-related claims incurred and the ability to adequately price the risks it assumes. While death claims are reasonably predictable over a period of many years, claims become less predictable over shorter periods and are subject to significant fluctuation from quarter to quarter and year to year. For longevity business, the Company’s profitability depends on the lifespan of the underlying contract holders and the investment performance for certain contracts. Additionally, the Company generates profits on investment spreads associated with the reinsurance of investment type contracts and generates fees from financial reinsurance transactions, which are typically shorter duration than its traditional life reinsurance business. The Company believes its sources of liquidity are sufficient to cover potential claims payments on both a short-term and long-term basis.
As is customary in the reinsurance business, clients continually update, refine, and revise reinsurance information provided to the Company. Such revised information is used by the Company in preparation of its condensed consolidated financial statements and the financial effects resulting from the incorporation of revised data are reflected in the current period.
Segment Presentation    
The Company has geographic-based and business-based operational segments. Geographic-based operations are further segmented into traditional and financial solutions businesses. The Company allocates capital to its segments based on an internally developed economic capital model, the purpose of which is to measure the risk in the business and to provide a consistent basis upon which capital is deployed. The economic capital model considers the unique and specific nature of the risks inherent in RGA’s businesses.
As a result of the economic capital allocation process, a portion of investment income is credited to the segments based on the level of allocated capital. In addition, the segments are charged for excess capital utilized above the allocated economic capital basis. This charge is included in policy acquisition costs and other insurance expenses. Segment investment performance varies with the composition of investments and the relative allocation of capital to the operating segments.
Segment revenue levels can be significantly influenced by currency fluctuations, large transactions, mix of business and reporting practices of ceding companies, and therefore may fluctuate from period to period. Although reasonably predictable over a period of years, segment claims experience can be volatile over shorter periods. See “Results of Operations by Segment” below for further information about the Company’s segments.



40

Table of Contents


Consolidated Results of Operations
The following table summarizes net income for the periods presented.
 
 
Three months ended March 31,
 
 
2019
 
2018
Revenues:
 
(Dollars in thousands, except per share data)
Net premiums
 
$
2,737,813

 
$
2,582,551

Investment income, net of related expenses
 
579,877

 
516,329

Investment related gains (losses), net:
 
 
 
 
Other-than-temporary impairments on fixed maturity securities
 
(9,453
)
 

Other investment related gains (losses), net
 
17,241

 
(470
)
Total investment related gains (losses), net
 
7,788

 
(470
)
Other revenues
 
94,553

 
75,297

Total revenues
 
3,420,031

 
3,173,707

Benefits and Expenses:
 
 
 
 
Claims and other policy benefits
 
2,508,324

 
2,362,101

Interest credited
 
133,189

 
80,449

Policy acquisition costs and other insurance expenses
 
311,881

 
356,902

Other operating expenses
 
201,483

 
191,274

Interest expense
 
40,173

 
37,454

Collateral finance and securitization expense
 
8,417

 
7,602

Total benefits and expenses
 
3,203,467

 
3,035,782

 Income before income taxes
 
216,564

 
137,925

Provision for income taxes
 
47,057

 
37,695

Net income
 
$
169,507

 
$
100,230

Earnings per share:
 
 
 
 
Basic earnings per share
 
$
2.70

 
$
1.55

Diluted earnings per share
 
$
2.65

 
$
1.52

Consolidated income before income taxes increased $78.6 million, or 57.0%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase in income for the first three months of 2019 was primarily due to improved results in the U.S. and Latin America, Canada and Asia Pacific segments and increased investment income. Foreign currency fluctuations resulted in a decrease in income before income taxes of $9.4 million for the first three months of 2019, as compared to the same period in 2018.
The Company recognizes in consolidated income, any changes in the fair value of embedded derivatives on modco or funds withheld treaties, equity-indexed annuity treaties (“EIAs”) and variable annuities with guaranteed minimum benefit riders. The Company utilizes freestanding derivatives to minimize the income statement volatility due to changes in the fair value of embedded derivatives associated with guaranteed minimum benefit riders. The following table presents the effect of embedded derivatives and related freestanding derivatives on income before income taxes for the periods indicated (dollars in thousands):


41

Table of Contents


 
Three months ended March 31,
 
2019
 
2018
Modco/Funds withheld:
 
 
 
Unrealized gains (losses)
$
(2,092
)
 
$
13,611

Deferred acquisition costs/retrocession
(2,857
)
 
(3,073
)
Net effect
(4,949
)
 
10,538

EIAs:
 
 
 
Unrealized gains (losses)
(1,518
)
 
28,563

Deferred acquisition costs/retrocession
875

 
(15,295
)
Net effect
(643
)
 
13,268

Guaranteed minimum benefit riders:
 
 
 
Unrealized gains (losses)
18,161

 
14,785

Deferred acquisition costs/retrocession
(16,774
)
 
2,333

Net effect
1,387

 
17,118

Related freestanding derivatives
(2,578
)
 
(22,500
)
Net effect after related freestanding derivatives
(1,191
)
 
(5,382
)
 
 
 
 
Total net effect of embedded derivatives
(4,205
)
 
40,924

Related freestanding derivatives
(2,578
)
 
(22,500
)
Total net effect after freestanding derivatives
$
(6,783
)
 
$
18,424

Net premiums increased $155.3 million, or 6.0%, for the three months ended March 31, 2019, as compared to the same period in 2018 due to new business production. The Company added new business production, measured by face amount of insurance in force, of $79.3 billion and $96.7 billion during the first three months of 2019 and 2018, respectively. Foreign currency fluctuations reduced net premiums by $78.8 million for the first three months of 2019, as compared to the same period in 2018. Consolidated assumed life insurance in force decreased to $3,364.6 billion as of March 31, 2019 from $3,383.8 billion as of March 31, 2018 due to foreign currency exchange fluctuations. Unfavorable foreign currency exchange fluctuations reduced assumed life insurance in force by $102.1 billion from March 31, 2018.
Investment income, net of related expenses, increased $63.5 million or 12.3%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase is largely attributable to an increase in the average asset base, and a slightly higher investment yield. Partially offsetting the increase in investment income was a decrease in the fair value attributed to the Company’s funds withheld at interest investment associated with the reinsurance of certain EIAs, which decreased investment income by $6.5 million in the first three months of 2019, as compared to the same period in 2018. The effect on investment income of the EIA's fair value changes is substantially offset by a corresponding change in interest credited to policyholder account balances resulting in an insignificant effect on net income.
Average invested assets at amortized cost, excluding spread related business, for the three months ended March 31, 2019 totaled $28.1 billion, a 4.1% increase over March 31, 2018. The average yield earned on investments, excluding spread related business, was 4.49% and 4.46% for the three months ended March 31, 2019 and 2018, respectively. The average yield will vary from quarter to quarter and year to year depending on a number of variables, including the prevailing interest rate and credit spread environment, prepayment fees and make-whole premiums, changes in the mix of the underlying investments and cash balances, and the timing of dividends and distributions on certain investments. A continued low interest rate environment is expected to put downward pressure on this yield in future reporting periods.
Investment related gains, net increased by $8.3 million for the three months ended March 31, 2019, as compared to the same period in 2018. The increase is primarily due to a decrease in realized losses of $18.4 million compared to the same period in 2018. The reduction in realized loss was partially offset by less favorable changes in the fair value of embedded derivatives on modco or funds withheld treaties in the current period compared to 2018 reflecting the impact of changes in interest rates and credit spreads on the calculation of fair value. Changes in the fair value associated with these embedded derivatives reduced investment related gains by $2.1 million for the first three months of 2019 compared to an increase of $13.6 million in the first three months of 2018. Impairments on fixed maturity securities increased by $9.5 million in the first three months of 2019, as compared to the same period in 2018. See Note 4 - “Investments” and Note 5 - “Derivative Instruments” in the Notes to Condensed Consolidated Financial Statements for additional information on the impairment losses and derivatives.
The effective tax rate on a consolidated basis was 21.7% and 27.3% for the first quarter 2019 and 2018, respectively. See Note 9 - “Income Tax” in the Notes to Condensed Consolidated Financial Statements for additional information on the Company’s consolidated effective tax rates.

42

Table of Contents



Critical Accounting Policies
The preparation of financial statements in conformity with GAAP requires the application of accounting policies that often involve a significant degree of judgment. Management, on an ongoing basis, reviews estimates and assumptions used in the preparation of financial statements. If management determines that modifications in assumptions and estimates are appropriate given current facts and circumstances, results of operations and financial position as reported in the condensed consolidated financial statements could change significantly.
Management believes the critical accounting policies relating to the following areas are most dependent on the application of estimates and assumptions:
Premiums receivable;
Deferred acquisition costs;
Liabilities for future policy benefits and incurred but not reported claims;
Valuation of investments and other-than-temporary impairments to specific investments;
Valuation of embedded derivatives; and
Income taxes.
A discussion of each of the critical accounting policies may be found in the Company’s 2018 Annual Report under “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies.”


43

Table of Contents


Results of Operations by Segment

U.S. and Latin America Operations
The U.S. and Latin America operations include business generated by its offices in the U.S., Mexico and Brazil. The offices in Mexico and Brazil provide services to clients in other Latin American countries. U.S. and Latin America operations consist of two major segments: Traditional and Financial Solutions. The Traditional segment primarily specializes in the reinsurance of individual mortality-risk, health and long-term care and to a lesser extent, group reinsurance. The Financial Solutions segment consists of Asset-Intensive and Financial Reinsurance. Asset-Intensive within the Financial Solutions segment includes coinsurance of annuities and corporate-owned life insurance policies and to a lesser extent fee-based synthetic guaranteed investment contracts, which include investment-only, stable value contracts. Financial Reinsurance within the Financial Solutions segment primarily involves assisting ceding companies in meeting applicable regulatory requirements by enhancing the ceding companies’ financial strength and regulatory surplus position through relatively low risk reinsurance transactions. Due to the low-risk nature of financial reinsurance transactions, they typically do not qualify as reinsurance under GAAP, so only the related net fees are reflected in other revenues on the condensed consolidated statements of income.
For the three months ended March 31, 2019:
 
 
 
Financial Solutions
 
 
(dollars in thousands)
 
 
 
Asset-Intensive
 
Financial
Reinsurance
 
Total U.S. and Latin America
 
 
Traditional
 
Revenues:
 
 
 
 
 
 
 
 
Net premiums
 
$
1,356,882

 
$
7,210

 
$

 
$
1,364,092

Investment income, net of related expenses
 
185,534

 
197,221

 
1,016

 
383,771

Investment related gains (losses), net
 
(6,472
)
 
1,046

 

 
(5,426
)
Other revenues
 
4,722

 
22,674

 
25,493

 
52,889

Total revenues
 
1,540,666

 
228,151

 
26,509

 
1,795,326

Benefits and expenses:
 
 
 
 
 
 
 
 
Claims and other policy benefits
 
1,300,065

 
48,099

 

 
1,348,164

Interest credited
 
19,874

 
88,710

 

 
108,584

Policy acquisition costs and other insurance expenses
 
176,003

 
19,233

 
5,376

 
200,612

Other operating expenses
 
33,070

 
7,151

 
2,814

 
43,035

Total benefits and expenses
 
1,529,012

 
163,193

 
8,190

 
1,700,395

Income before income taxes
 
$
11,654

 
$
64,958

 
$
18,319


$
94,931

 
 
 
 
 
 
 
 
 
For the three months ended March 31, 2018:
 
 
 
Financial Solutions
 
 
(dollars in thousands)
 
 
 
Asset-Intensive
 
Financial
Reinsurance
 
Total U.S. and Latin America
 
 
Traditional
 
Revenues:
 
 
 
 
 
 
 
 
Net premiums
 
$
1,299,422

 
$
5,192

 
$

 
$
1,304,614

Investment income, net of related expenses
 
183,060

 
157,912

 
1,822

 
342,794

Investment related gains (losses), net
 
1,683

 
676

 

 
2,359

Other revenues
 
5,529

 
22,959

 
24,791

 
53,279

Total revenues
 
1,489,694

 
186,739

 
26,613

 
1,703,046

Benefits and expenses:
 
 
 
 
 
 
 
 
Claims and other policy benefits
 
1,254,961

 
15,945

 

 
1,270,906

Interest credited
 
20,280

 
54,212

 

 
74,492

Policy acquisition costs and other insurance expenses
 
177,640

 
62,035

 
4,000

 
243,675

Other operating expenses
 
33,921

 
7,285

 
2,454

 
43,660

Total benefits and expenses
 
1,486,802

 
139,477

 
6,454

 
1,632,733

Income before income taxes
 
$
2,892

 
$
47,262

 
$
20,159


$
70,313

Income before income taxes increased by $24.6 million, or 35.0%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase in income before income taxes was primarily due to the impact of higher investment related gains (losses) in the Asset-Intensive segment as well as improved claims experience within the U.S. Traditional segment. Offsetting these somewhat was the change in the value of the embedded derivatives associated with reinsurance treaties structured on a modco or funds withheld basis, net of the corresponding impact to deferred acquisition costs.
Traditional Reinsurance
Income before income taxes for the U.S. and Latin America Traditional segment increased by $8.8 million for the three months ended March 31, 2019, as compared to the same period in 2018. The increase is primarily due to improved claims experience in 2019 from both individual mortality and group business.

44

Table of Contents


Net premiums increased $57.5 million, or 4.4%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase was primarily due to organic growth combined with strong new business in the first quarter of 2019. The segment added new individual life business production, measured by face amount of insurance in force of $28.8 billion and $23.3 billion in the first three months of 2019 and 2018, respectively.
Net investment income increased $2.5 million, or 1.4%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase was due to an increase in the invested asset base, partially offset by lower variable investment income quarter over quarter. Investment related gains (losses), net decreased $8.2 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Claims and other policy benefits as a percentage of net premiums (“loss ratios”) were 95.8% and 96.6% for the three months ended March 31, 2019 and 2018, respectively. The decrease in the loss ratio in 2019 was primarily due to unfavorable 2018 claims experience in traditional individual mortality, associated with the influenza season, and the group disability line of business.
Interest credited expense decreased by $0.4 million, or 2.0%, for the three months ended March 31, 2019, as compared to the same period in 2018. Interest credited in this segment relates to amounts credited on cash value products, which also have a significant mortality component. Income before income taxes is affected by the spread between the investment income and the interest credited on the underlying products.
Policy acquisition costs and other insurance expenses as a percentage of net premiums were 13.0% and 13.7% for the three months ended March 31, 2019 and 2018, respectively. While these ratios are expected to remain in a predictable range, they may fluctuate from period to period due to varying allowance levels within coinsurance-type arrangements. In addition, the amortization pattern of previously capitalized amounts, which are subject to the form of the reinsurance agreement and the underlying insurance policies, may vary. Also, the mix of first year coinsurance business versus yearly renewable term business can cause the percentage to fluctuate from period to period.
Other operating expenses decreased $0.9 million, or 2.5%, for the three months ended March 31, 2019, as compared to the same period in 2018 due to decreased variable compensation. Other operating expenses as a percentage of net premiums were 2.4% and 2.6% for the three month periods ended March 31, 2019 and 2018, respectively. The expense ratio tends to fluctuate only slightly from period to period due to the maturity and scale of this segment.
Financial Solutions - Asset-Intensive Reinsurance
Asset-Intensive reinsurance within the U.S. and Latin America Financial Solutions segment primarily involves assuming investment risk within underlying annuities and corporate-owned life insurance policies. Most of these agreements are coinsurance, coinsurance with funds withheld or modco. The Company recognizes profits or losses primarily from the spread between the investment income earned and the interest credited on the underlying deposit liabilities, income associated with longevity risk, and fees associated with variable annuity account values and guaranteed investment contracts.
Impact of certain derivatives:
Income from the asset-intensive business tends to be volatile due to changes in the fair value of certain derivatives, including embedded derivatives associated with reinsurance treaties structured on a modco or funds withheld basis, as well as embedded derivatives associated with the Company’s reinsurance of equity-indexed annuities and variable annuities with guaranteed minimum benefit riders. Fluctuations occur period to period primarily due to changing investment conditions including, but not limited to, interest rate movements (including risk-free rates and credit spreads), implied volatility, the Company’s own credit risk and equity market performance, all of which are factors in the calculations of fair value. Therefore, management believes it is helpful to distinguish between the effects of changes in these derivatives, net of related hedging activity, and the primary factors that drive profitability of the underlying treaties, namely investment income, fee income (included in other revenues), and interest credited. These fluctuations are considered unrealized by management and do not affect current cash flows, crediting rates or spread performance on the underlying treaties.
The following table summarizes the asset-intensive results and quantifies the impact of these embedded derivatives for the periods presented. Revenues before certain derivatives, benefits and expenses before certain derivatives, and income before income taxes and certain derivatives should not be viewed as substitutes for GAAP revenues, GAAP benefits and expenses, and GAAP income before income taxes.

45

Table of Contents


(dollars in thousands)
 
Three months ended March 31,
 
 
2019
 
2018
Revenues:
 
 
 
 
Total revenues
 
$
228,151

 
$
186,739

Less:
 
 
 
 
Embedded derivatives – modco/funds withheld treaties
 
4,383

 
11,918

Guaranteed minimum benefit riders and related free standing derivatives
 
(2,835
)
 
(4,588
)
Revenues before certain derivatives
 
226,603

 
179,409

Benefits and expenses:
 
 
 
 
Total benefits and expenses
 
163,193

 
139,477

Less:
 
 
 
 
Embedded derivatives – modco/funds withheld treaties
 
2,857

 
3,073

Guaranteed minimum benefit riders and related free standing derivatives
 
(1,644
)
 
794

Equity-indexed annuities
 
643

 
(13,268
)
Benefits and expenses before certain derivatives
 
161,337

 
148,878

Income before income taxes:
 
 
 
 
Income before income taxes
 
64,958

 
47,262

Less:
 
 
 
 
Embedded derivatives – modco/funds withheld treaties
 
1,526

 
8,845

Guaranteed minimum benefit riders and related free standing derivatives
 
(1,191
)
 
(5,382
)
Equity-indexed annuities
 
(643
)
 
13,268

Income before income taxes and certain derivatives
 
$
65,266

 
$
30,531

Embedded Derivatives - Modco/Funds Withheld Treaties - Represents the change in the fair value of embedded derivatives on funds withheld at interest associated with treaties written on a modco or funds withheld basis. The fair value changes of embedded derivatives on funds withheld at interest associated with treaties written on a modco or funds withheld basis are reflected in revenues, while the related impact on deferred acquisition expenses is reflected in benefits and expenses. The Company’s utilization of a credit valuation adjustment did not have a material effect on the change in fair value of these embedded derivatives for the three months ended March 31, 2019 and 2018.
The change in fair value of the embedded derivatives - modco/funds withheld treaties increased income before income taxes by $1.5 million and $8.8 million for the three months ended March 31, 2019 and 2018, respectively. The increase in income for the three months ended March 31, 2019 and 2018 was primarily due to tightening credit spreads.
Guaranteed Minimum Benefit Riders - Represents the impact related to guaranteed minimum benefits associated with the Company’s reinsurance of variable annuities. The fair value changes of the guaranteed minimum benefits along with the changes in fair value of the free standing derivatives (interest rate swaps, financial futures and equity options), purchased by the Company to substantially hedge the liability are reflected in revenues, while the related impact on deferred acquisition expenses is reflected in benefits and expenses. The Company’s utilization of a credit valuation adjustment did not have a material effect on the change in fair value of these embedded derivatives for the three months ended March 31, 2019 and 2018.
The change in fair value of the guaranteed minimum benefits, after allowing for changes in the associated free standing derivatives, decreased income before income taxes by $1.2 million and $5.4 million for the three months ended March 31, 2019 and 2018, respectively. The decrease in income for the three months ended March 31, 2019 and 2018 was primarily due to interest rate movements.
Equity-Indexed Annuities - Represents changes in the liability for equity-indexed annuities in excess of changes in account value, after adjustments for related deferred acquisition expenses. The change in fair value of embedded derivative liabilities associated with equity-indexed annuities decreased income before income taxes by $0.6 million and increased by $13.3 million for the three months ended March 31, 2019 and 2018, respectively.  The decrease in income for the three months ended March 31, 2019 was due to interest rate movements. The increase for the three months ended March 31, 2018 was primarily due to lower policyholder lapses and withdrawals.

46

Table of Contents


The changes in derivatives discussed above are considered unrealized by management and do not affect current cash flows, crediting rates or spread performance on the underlying treaties. Fluctuations occur period to period primarily due to changing investment conditions including, but not limited to, interest rate movements (including benchmark rates and credit spreads), credit valuation adjustments, implied volatility and equity market performance, all of which are factors in the calculations of fair value. Therefore, management believes it is helpful to distinguish between the effects of changes in these derivatives and the primary factors that drive profitability of the underlying treaties, namely investment income, fee income (included in other revenues) and interest credited.
Discussion and analysis before certain derivatives:
Income before income taxes and certain derivatives increased by $34.7 million for the three months ended March 31, 2019, as compared to the same period in 2018. The increase was primarily due to higher investment related gains (losses), net of the corresponding impact to deferred acquisition costs, associated with coinsurance and funds withheld portfolios and the contribution from transactions executed in the second half of 2018. Funds withheld capital gains (losses) are reported in investment income.
Revenue before certain derivatives increased by $47.2 million for the three months ended March 31, 2019, as compared to the same period in 2018. The increase in the first quarter was primarily due to the contribution from transactions executed in the second half of 2018 and higher investment related gains (losses) associated with coinsurance and funds withheld portfolios.
Benefits and expenses before certain derivatives increased by $12.5 million for the three months ended March 31, 2019, as compared to the same period in 2018. The increase in the first quarter of 2019 was primarily due to the contribution from transactions executed in the second half of 2018.
The invested asset base supporting this segment increased to $19.9 billion as of March 31, 2019 from $16.0 billion as of March 31, 2018 due to transactions executed in the second half of 2018. As of March 31, 2019, $3.8 billion of the invested assets were funds withheld at interest, of which greater than 90% is associated with one client.
Financial Solutions - Financial Reinsurance
Financial Reinsurance within the U.S. and Latin America Financial Solutions segment income before income taxes consists primarily of net fees earned on financial reinsurance transactions. Additionally, a portion of the business is brokered business in which the Company does not participate in the assumption of risk. The fees earned from financial reinsurance contracts and brokered business are reflected in other revenues, and the fees paid to retrocessionaires are reflected in policy acquisition costs and other insurance expenses.
Income before income taxes decreased $1.8 million, or 9.1%, for the three months ended March 31, 2019, as compared to the same period in 2018. The decrease was primarily due to the termination of certain agreements.
As of March 31, 2019 and 2018, the amount of reinsurance assumed from client companies, as measured by pre-tax statutory surplus, risk based capital and other financial structures was $14.6 billion and $13.3 billion, respectively. The increase was primarily due to a number of new transactions offsetting the termination of certain agreements, as well as organic growth on existing transactions. Fees earned from this business can vary significantly depending on the size of the transactions and the timing of their completion and therefore can fluctuate from period to period.

47

Table of Contents


Canada Operations
The Company conducts reinsurance business in Canada primarily through RGA Canada. The Canada operations are primarily engaged in Traditional reinsurance, which consists mainly of traditional individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. Creditor insurance covers the outstanding balance on personal, mortgage or commercial loans in the event of death, disability or critical illness and is generally shorter in duration than traditional individual life insurance. The Canada Financial Solutions segment consists of longevity and financial reinsurance.
(dollars in thousands)
Three months ended March 31,
 
2019
 
2018
Revenues:
Traditional
 
Financial Solutions
 
Total Canada
 
Traditional
 
Financial Solutions
 
Total Canada
Net premiums
$
255,257

 
$
21,989

 
$
277,246

 
$
252,723

 
$
11,305

 
$
264,028

Investment income, net of related expenses
49,693

 
718

 
50,411

 
50,584

 
115

 
50,699

Investment related gains (losses), net
7,404

 

 
7,404

 
(731
)
 

 
(731
)
Other revenues
(21
)
 
867

 
846

 
(257
)
 
1,357

 
1,100

Total revenues
312,333

 
23,574

 
335,907

 
302,319

 
12,777

 
315,096

Benefits and expenses:
 
 
 
 
 
 
 
 
 
 
 
Claims and other policy benefits
199,856

 
21,153

 
221,009

 
212,825

 
9,115

 
221,940

Interest credited
55

 

 
55

 
5

 

 
5

Policy acquisition costs and other insurance expenses
53,908

 
449

 
54,357

 
57,032

 
96

 
57,128

Other operating expenses
8,235

 
624

 
8,859

 
8,750

 
375

 
9,125

Total benefits and expenses
262,054

 
22,226

 
284,280

 
278,612

 
9,586

 
288,198

Income before income taxes
$
50,279

 
$
1,348

 
$
51,627

 
$
23,707

 
$
3,191

 
$
26,898

Income before income taxes increased by $24.7 million, or 91.9%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase in income in the first three months of 2019 is primarily due to favorable traditional individual life mortality experience as compared to the same period in 2018. Foreign currency exchange fluctuation in the Canadian dollar resulted in a decrease in income before income taxes of $2.6 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Traditional Reinsurance
Income before income taxes for the Canada Traditional segment increased by $26.6 million, or 112.1%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase in income before income taxes in 2019 is primarily due to favorable traditional individual life mortality experience. Foreign currency exchange fluctuation in the Canadian dollar resulted in a decrease in income before income taxes of $2.6 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Net premiums increased $2.5 million, or 1.0%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase in 2019 was primarily due to a new inforce block transaction during the last quarter of 2018. Foreign currency exchange fluctuation in the Canadian dollar resulted in a decrease in net premiums of $12.7 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Net investment income decreased $0.9 million, or 1.8%, for the three months ended March 31, 2019, as compared to the same period in 2018. The decrease in 2019 is primarily a result of foreign currency exchange fluctuation in the Canadian dollar partially offset by an increase in the invested asset base due to growth in underlying business volume. Foreign currency exchange fluctuation in the Canadian dollar resulted in a decrease in net investment income of $2.6 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Investment related gains (losses), net increased by $8.1 million for the three months ended March 31, 2019, as compared to the same period in 2018. The increase in 2019 was primarily due to an increase in the fair market value of derivatives.
Loss ratios were 78.3% and 84.2% for the three months ended March 31, 2019 and 2018, respectively. The decrease in the loss ratio for the first quarter of 2019, as compared to the same period in 2018, is due to favorable traditional individual life mortality experience and the aforementioned new inforce block transaction in the last quarter of 2018. Loss ratios for the traditional individual life mortality business were 83.5% and 91.3% for the first three months ended March 31, 2019 and 2018, respectively. Excluding creditor business, claims as a percentage of net premiums for this segment were 73.2% and 77.0% for the three months ended March 31, 2019 and 2018, respectively. Historically, the loss ratio increased primarily as the result of several large permanent level premium in force blocks assumed in 1997 and 1998. These blocks are mature blocks of long-term permanent level premium business in which mortality as a percentage of net premiums is expected to be higher than historical ratios. The nature of permanent

48

Table of Contents


level premium policies requires the Company to set up actuarial liabilities and invest the amounts received in excess of early-year claims costs to fund claims in later years when premiums, by design, continue to be level as compared to expected increasing mortality or claim costs. As such, investment income becomes a more significant component of profitability of these in force blocks. Excluding creditor business, claims and other policy benefits, as a percentage of net premiums and investment income were 70.1% and 75.3% for the three months ended March 31, 2019 and 2018, respectively.
Policy acquisition costs and other insurance expenses as a percentage of net premiums were 21.1% and 22.6% for the three months ended March 31, 2019 and 2018, respectively. Overall, while these ratios are expected to remain in a predictable range, they may fluctuate from period to period due to varying allowance levels and product mix. In addition, the amortization patterns of previously capitalized amounts, which are subject to the form of the reinsurance agreement and the underlying insurance policies, may vary.
Other operating expenses decreased by $0.5 million, or 5.9%, for the three months ended March 31, 2019, as compared to the same period in 2018. Other operating expenses as a percentage of net premiums were 3.2% and 3.5% for the three months ended March 31, 2019 and 2018, respectively.
Financial Solutions Reinsurance
Income before income taxes decreased by $1.8 million, or 57.8%, for the three months ended March 31, 2019, as compared to the same period in 2018. The decrease in income in the first three months was primarily due to unfavorable experience on longevity business. Foreign currency exchange fluctuation in the Canadian dollar resulted in a decrease in income before income taxes of $0.1 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Net premiums increased $10.7 million, or 94.5%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase was primarily due to a new financial solutions reinsurance transaction completed in the first three months of 2019. Foreign currency exchange fluctuation in the Canadian dollar resulted in a decrease in net premiums of $1.0 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Net investment income increased $0.6 million for the three months ended March 31, 2019, as compared to the same period in 2018 primarily due to an increase in the invested asset base.
Claims and other policy benefits increased $12.0 million, or 132.1%, for the three months ended March 31, 2019 as compared to the same period in 2018. The increase was primarily a result of the aforementioned new financial solutions reinsurance transaction completed in the first three months of 2019.

Europe, Middle East and Africa Operations
The Europe, Middle East and Africa (“EMEA”) operations include business generated by its offices principally in France, Germany, Ireland, Italy, the Middle East, the Netherlands, Poland, South Africa, Spain and the United Kingdom (“UK”). EMEA consists of two major segments: Traditional and Financial Solutions. The Traditional segment primarily provides reinsurance through yearly renewable term and coinsurance agreements on a variety of life, health and critical illness products. Reinsurance agreements may be facultative or automatic agreements covering primarily individual risks and, in some markets, group risks. The Financial Solutions segment consists of reinsurance and other transactions associated with longevity closed blocks, payout annuities, capital management solutions and financial reinsurance.
(dollars in thousands)
Three months ended March 31,
 
2019
 
2018
Revenues:
Traditional
 
Financial Solutions
 
Total EMEA
 
Traditional
 
Financial Solutions
 
Total EMEA
Net premiums
$
363,884

 
$
52,101

 
$
415,985

 
$
375,729

 
$
47,979

 
$
423,708

Investment income, net of related expenses
18,802

 
48,665

 
67,467

 
15,764

 
31,932

 
47,696

Investment related gains (losses), net

 
3,364

 
3,364

 
9

 
3,352

 
3,361

Other revenues
1,320

 
5,291

 
6,611

 
2,280

 
4,880

 
7,160

Total revenues
384,006

 
109,421

 
493,427

 
393,782

 
88,143

 
481,925

Benefits and expenses:
 
 
 
 
 
 
 
 
 
 
 
Claims and other policy benefits
312,135

 
48,878

 
361,013

 
326,802

 
42,471

 
369,273

Interest credited

 
12,342

 
12,342

 

 
(2,652
)
 
(2,652
)
Policy acquisition costs and other insurance expenses
29,953

 
631

 
30,584

 
25,552

 
1,080

 
26,632

Other operating expenses
26,494

 
9,180

 
35,674

 
26,007

 
8,080

 
34,087

Total benefits and expenses
368,582

 
71,031

 
439,613

 
378,361

 
48,979

 
427,340

Income (loss) before income taxes
$
15,424

 
$
38,390

 
$
53,814

 
$
15,421

 
$
39,164

 
$
54,585


49

Table of Contents


Income before income taxes decreased by $0.8 million, or 1.4%, for the three months ended March 31, 2019, as compared to the same period in 2018. The decrease in income before income taxes for the first three months was primarily due to foreign exchange fluctuations and the normalization of performance on closed longevity blocks and payout annuities after favorable performance in 2018. Foreign currency exchange fluctuations resulted in a decrease in income before income taxes totaling $4.5 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Traditional Reinsurance
Income before income taxes for the three months ended March 31, 2019 was consistent with the same period in 2018. Foreign currency exchange fluctuations resulted in a decrease in income before income taxes totaling $1.7 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Net premiums decreased $11.8 million, or 3.2%, for the three months ended March 31, 2019, as compared to the same period in 2018 with an increase in business volume on existing treaties more than offset by unfavorable foreign currency fluctuations. Foreign currency exchange fluctuations decreased net premiums by $32.6 million for the three months ended March 31, 2019, as compared to the same period in 2018.
A portion of the net premiums for the segment, in each period presented, relates to reinsurance of critical illness coverage, primarily in the UK. This coverage provides a benefit in the event of the diagnosis of a pre-defined critical illness. Net premiums earned from this coverage totaled $44.4 million and $48.9 million for the first three months of 2019 and 2018, respectively.
Net investment income increased $3.0 million, or 19.3%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase for the first three months of 2019 was primarily due to an increase in the invested asset base and an increase in the investment yield. Foreign currency exchange fluctuation resulted in a decrease in net investment income of $1.7 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Loss ratios for this segment were 85.8% and 87.0% for the three month periods ended March 31, 2019 and 2018, respectively. The slight decrease in the loss ratio for the first three months of 2019 is primarily due to changes in business mix reflecting increased volumes of business with lower loss ratios, but with higher allowances. These higher allowances are reflected in the increase in the policy acquisition cost ratio.
Policy acquisition costs and other insurance expenses as a percentage of net premiums were 8.2% and 6.8% for the three months ended March 31, 2019 and 2018, respectively. The increase in policy acquisition cost ratio is due primarily to changes in the mix of business reflecting increased volumes of business with higher allowances.
Other operating expenses increased $0.5 million, or 1.9%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase is in line with expected expense levels needed to support the business as well as higher incentive compensation. Other operating expenses as a percentage of net premiums totaled 7.3% and 6.9% for the three months ended March 31, 2019 and 2018, respectively.
Financial Solutions Reinsurance
Income before income taxes decreased by $0.8 million, or 2.0%, for the three months ended March 31, 2019, as compared to the same period in 2018. The decrease in income before income taxes for the first three months was primarily due to foreign exchange fluctuations and the normalization of performance on closed longevity blocks and payout annuities after favorable performance in 2018. Foreign currency exchange fluctuations resulted in a decrease in income before income taxes totaling $2.8 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Net premiums increased $4.1 million, or 8.6%, for the three months ended March 31, 2019, as compared to the same period in 2018. Net premiums increased primarily due to increased volumes of closed longevity block business. Foreign currency exchange fluctuations decreased net premiums by $3.6 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Net investment income increased $16.7 million, or 52.4%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase was primarily due to an increase in investment income associated with unit-linked policies, which fluctuate with market performance. The effect on investment income related to unit-linked products is substantially offset by a corresponding change in interest credited. Foreign currency exchange fluctuation resulted in a decrease in investment income of $3.6 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Other revenues increased by $0.4 million, or 8.4%, for the three months ended March 31, 2019, as compared to the same period in 2018. Fees earned from this business can vary significantly depending on the size of the transactions and the timing of their completion and, therefore, can fluctuate from period to period.

50

Table of Contents


Claims and other policy benefits increased $6.4 million, or 15.1%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase in claims and other policy benefits was primarily due to increased volumes of closed longevity block business as well as a normalization of performance compared to favorable performance in 2018. Foreign currency exchange fluctuations decreased claims and other policy benefits by $3.4 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Interest credited expense increased by $15.0 million for the three months ended March 31, 2019, as compared to the same period in 2018. Interest credited in this segment relates to amounts credited to the contractholders of unit-linked products. The effect on interest credited related to unit-linked products is substantially offset by a corresponding change in investment income.
Other operating expenses increased $1.1 million, or 13.6%, for the three months ended March 31, 2019, as compared to the same period in 2018, with the increase primarily due to business acquisition related costs. Foreign currency exchange fluctuations decreased other operating expenses by $0.7 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Asia Pacific Operations
The Asia Pacific operations include business generated by its offices principally in Australia, China, Hong Kong, India, Japan, Malaysia, New Zealand, Singapore, South Korea and Taiwan. The Traditional segment’s principal types of reinsurance include individual and group life and health, critical illness, disability and superannuation. Superannuation is the Australian government mandated compulsory retirement savings program. Superannuation funds accumulate retirement funds for employees, and, in addition, typically offer life and disability insurance coverage. The Financial Solutions segment includes financial reinsurance and asset-intensive transactions including certain disability, life and health blocks with significant investment risk. Reinsurance agreements may be facultative or automatic agreements covering primarily individual risks and in some markets, group risks.
(dollars in thousands)
Three months ended March 31,
 
2019
 
2018
Revenues:
Traditional
 
Financial Solutions
 
Total Asia Pacific
 
Traditional
 
Financial Solutions
 
Total Asia Pacific
Net premiums
$
646,741

 
$
33,795

 
$
680,536

 
$
589,513

 
$
678

 
$
590,191

Investment income, net of related expenses
25,335

 
10,269

 
35,604

 
24,600

 
10,394

 
34,994

Investment related gains (losses), net
8

 
4,069

 
4,077

 
8

 
3,467

 
3,475

Other revenues
1,088

 
6,395

 
7,483

 
418

 
5,307

 
5,725

Total revenues
673,172

 
54,528

 
727,700

 
614,539

 
19,846

 
634,385

Benefits and expenses:
 
 
 
 
 
 
 
 
 
 
 
Claims and other policy benefits
546,454

 
31,719

 
578,173

 
495,194

 
4,468

 
499,662

Interest credited

 
6,702

 
6,702

 

 
6,394

 
6,394

Policy acquisition costs and other insurance expenses
50,323

 
5,379

 
55,702

 
58,782

 
1,197

 
59,979

Other operating expenses
39,771

 
4,645

 
44,416

 
37,676

 
3,766

 
41,442

Total benefits and expenses
636,548

 
48,445

 
684,993

 
591,652

 
15,825

 
607,477

Income before income taxes
$
36,624

 
$
6,083

 
$
42,707

 
$
22,887

 
$
4,021

 
$
26,908

Income before income taxes increased by $15.8 million, or 58.7%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase in income before income taxes for the first three months is primarily attributable to favorable overall experience in Asia, partially offset by a loss in Australia. Foreign currency exchange fluctuations resulted in a decrease to income before income taxes totaling $2.0 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Traditional Reinsurance
Income before income taxes increased by $13.7 million, or 60.0%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase in income before income taxes in 2019 was primarily due to more profitable new business and favorable claims experience in Asia as compared to the prior year same quarter. Foreign currency exchange fluctuations resulted in a decrease to income before income taxes totaling $2.2 million for the three months ended 2019, as compared to the same period in 2018.
Net premiums increased by $57.2 million, or 9.7%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase for the three month period in 2019 was driven by new business growth. Foreign currency exchange fluctuations resulted in a decrease in net premiums of $27.2 million for the three months ended March 31, 2019, as compared to the same period in 2018.

51

Table of Contents


A portion of the net premiums for the segment, in each period presented, relates to reinsurance of critical illness coverage. This coverage provides a benefit in the event of the diagnosis of a pre-defined critical illness. Reinsurance of critical illness in the segment is offered primarily in South Korea, Australia, China and Hong Kong. Net premiums earned from this coverage totaled $252.1 million and $235.7 million for the three months ended March 31, 2019 and 2018, respectively.
Net investment income increased $0.7 million, or 3.0%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase was primarily due to an increase in the invested asset base. Foreign currency exchange fluctuations resulted in a decrease in net investment income of $1.7 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Loss ratios for this segment were 84.5% and 84.0% for the three months ended March 31, 2019 and 2018, respectively. The increase in the loss ratio for the first three months of 2019 was primarily due to unfavorable claims experience in Australia, partially offset by net favorable claims experience across Asia compared to the prior year same quarter.
Policy acquisition costs and other insurance expenses as a percentage of net premiums were 7.8% and 10.0% for the three months ended March 31, 2019 and 2018, respectively. The ratio of policy acquisition costs and other insurance expenses as a percentage of net premiums fluctuates periodically due to timing of client company reporting and variations in the mixture of business. The decrease in the current quarter is primarily due to higher allowances based on updated client reporting in the prior year.
Other operating expenses increased $2.1 million or 5.6%, for the three months ended March 31, 2019, as compared to the same period in 2018 mainly due to growth in headcount across Asia to manage the business growth in the region. Foreign currency exchange fluctuations resulted in a decrease in other operating expenses of $1.8 million for the three months ended March 31, 2019, as compared to the same period in 2018. Other operating expenses as a percentage of net premiums totaled 6.1% and 6.4% for the three months ended March 31, 2019 and 2018, respectively. The timing of premium flows and the level of costs associated with development of new markets within the segment may cause other operating expenses as a percentage of net premiums to fluctuate from period to period.
Financial Solutions Reinsurance
Income before income taxes increased by $2.1 million, or 51.3%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase in income before income taxes is primarily attributable to favorable lapse experience on a closed treaty in Japan and new transactions in Asia. Foreign currency exchange fluctuations increased income before income taxes by $0.2 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Net premiums increased $33.1 million for the three months ended March 31, 2019, as compared to the same period in 2018. The increase was primarily due to new asset-intensive transactions in Asia.
Net investment income decreased $0.1 million, or 1.2%, for the three months ended March 31, 2019, as compared to the same period in 2018. Foreign currency exchange fluctuation resulted in a decrease in net investment income of $0.4 million for the three months ended March 31, 2019, as compared to the same period in 2018.
Other revenues increased by $1.1 million, or 20.5%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase compared to the same period in 2018 is primarily due to higher income from new financial reinsurance transactions. As of March 31, 2019 and 2018, the amount of reinsurance assumed from client companies, as measured by pre-tax statutory surplus, risk based capital and other financial reinsurance structures was $3.1 billion and $2.6 billion, respectively. Fees earned from this business can vary significantly depending on the size of the transactions and the timing of their completion and, therefore, can fluctuate from period to period.
Claims and other policy benefits increased by $27.3 million for the three months ended March 31, 2019, as compared to the same period in 2018. This increase is attributable to new asset-intensive transactions in Asia.
Interest credited expense increased by $0.3 million, or 4.8%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase is primarily driven by growth from new asset-intensive transactions.
Other operating expenses increased $0.9 million, or 23.3%, for the three months ended March 31, 2019, as compared to the same period in 2018. The timing of premium flows and the level of costs associated with new transactions and the entrance into and development of new markets within the segment may cause other operating expenses to fluctuate from period to period.
Corporate and Other
Corporate and Other revenues primarily include investment income from unallocated invested assets, investment related gains and losses and service fees. Corporate and Other expenses consist of the offset to capital charges allocated to the operating segments within the policy acquisition costs and other insurance income line item, unallocated overhead and executive costs, interest expense

52

Table of Contents


related to debt, and the investment income and expense associated with the Company’s collateral finance and securitization transactions and service business expenses. Additionally, Corporate and Other includes results from certain wholly-owned subsidiaries, such as RGAx, and joint ventures that, among other activities, develop and market technology, and provide consulting and outsourcing solutions for the insurance and reinsurance industries. In the past two years, the Company has increased its investment and expenditures in this area in an effort to both support its clients and generate new future revenue streams.
(dollars in thousands)
 
Three months ended March 31,
 
 
2019
 
2018
Revenues:
 
 
 
 
Net premiums
 
$
(46
)
 
$
10

Investment income, net of related expenses
 
42,624

 
40,146

Investment related gains (losses), net
 
(1,631
)
 
(8,934
)
Other revenues
 
26,724

 
8,033

Total revenues
 
67,671

 
39,255

Benefits and expenses:
 
 
 
 
Claims and other policy benefits
 
(35
)
 
320

Interest credited
 
5,506

 
2,210

Policy acquisition costs and other insurance income
 
(29,374
)
 
(30,512
)
Other operating expenses
 
69,499

 
62,960

Interest expense
 
40,173

 
37,454

Collateral finance and securitization expense
 
8,417

 
7,602

Total benefits and expenses
 
94,186

 
80,034

Loss before income taxes
 
$
(26,515
)
 
$
(40,779
)
Loss before income taxes decreased by $14.3 million, or 35.0%, for the three months ended March 31, 2019, as compared to the same period in 2018. The decrease in loss before income taxes in the first quarter was primarily due to increases in investment income and other revenues and a decrease in net investment related losses, which are partially offset by an increase in other operating expenses.
Net investment income increased by $2.5 million, or 6.2%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase in the first quarter was largely attributable to an increase in unallocated invested assets and a higher average investment yield.
Net investment related losses decreased by $7.3 million, or 81.7%, for the three months ended March 31, 2019, as compared to the same period in 2018. The decrease in the first quarter was primarily due to an increase in net gains on the sale of fixed maturity securities of $5.1 million and an increase in the fair value of equity securities of $8.1 million, which were offset by a $3.7 million increase in other-than-temporary impairments on fixed maturity securities and other investments.
Other revenues increased by $18.7 million for the three months ended March 31, 2019, as compared to the same period in 2018. The increase in the first quarter was mainly due to a recapture of a collateral finance transaction, which resulted in a $12.9 million gain. In addition, the Company’s RGAx operations contributed $11.1 million to other revenues in 2019 compared to $6.5 million in 2018.
Policy acquisition costs and other insurance income increased by $1.1 million, or 3.7%, for the three months ended March 31, 2019, as compared to the same period in 2018. Fluctuations period over period were attributable to the offset to capital charges allocated to the operating segments.
Other operating expenses increased by $6.5 million, or 10.4%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase in other operating expenses was primarily due to strategic initiatives such as RGAx, and increased incentive-based compensation.
Interest expense increased by $2.7 million, or 7.3%, for the three months ended March 31, 2019, as compared to the same period in 2018. The increase in interest expense was due to variability in tax-related interest expense.
Liquidity and Capital Resources
Overview
The Company believes that cash flows from the source of funds available to it will provide sufficient cash flows for the next twelve months to satisfy the current liquidity requirements of the Company under various scenarios that include the potential risk of early recapture of reinsurance treaties, market events and higher than expected claims. The Company performs periodic liquidity stress

53

Table of Contents


testing to ensure its asset portfolio includes sufficient high quality liquid assets that could be utilized to bolster its liquidity position under stress scenarios. These assets could be utilized as collateral for secured borrowing transactions with various third parties or by selling the securities in the open market if needed. The Company’s liquidity requirements have been and will continue to be funded through net cash flows from operations. However, in the event of significant unanticipated cash requirements beyond normal liquidity needs, the Company has multiple liquidity alternatives available based on market conditions and the amount and timing of the liquidity need. These alternatives include borrowings under committed credit facilities, secured borrowings, the ability to issue long-term debt, preferred securities or common equity and, if necessary, the sale of invested assets subject to market conditions.
Current Market Environment
The current low interest rate environment in select markets, primarily the U.S., Canada and Europe, continues to put downward pressure on the Company's investment yield. The Company’s average investment yield, excluding spread business, for the three months ended March 31, 2019 was 4.49%, three basis points above the same period in 2018. The Company’s insurance liabilities, in particular its annuity products, are sensitive to changing market factors. Gross unrealized gains on fixed maturity securities available-for-sale increased from $1,858.7 million at December 31, 2018 to $2,780.0 million at March 31, 2019. Similarly, gross unrealized losses decreased from $748.5 million at December 31, 2018 to $230.2 million at March 31, 2019.
The Company continues to be in a position to hold any investment security showing an unrealized loss until recovery, provided it remains comfortable with the credit of the issuer. As indicated above, gross unrealized gains on fixed maturity securities of $2,780.0 million remain well in excess of gross unrealized losses of $230.2 million as of March 31, 2019. The Company does not rely on short-term funding or commercial paper and to date it has experienced no liquidity pressure, nor does it anticipate such pressure in the foreseeable future.
The Company projects its reserves to be sufficient, and it would not expect to write down deferred acquisition costs or be required to take any actions to augment capital, even if interest rates remain at current levels for the next five years, assuming all other factors remain constant. While the Company has felt the pressures of sustained low interest rates and volatile equity markets and may continue to do so, its business operations are not overly sensitive to these risks. Although management believes the Company’s current capital base is adequate to support its business at current operating levels, it continues to monitor new business opportunities and any associated new capital needs that could arise from the changing financial landscape.
The Holding Company
RGA is an insurance holding company whose primary uses of liquidity include, but are not limited to, the immediate capital needs of its operating companies, dividends paid to its shareholders, repurchase of common stock and interest payments on its indebtedness. The primary sources of RGA’s liquidity include proceeds from its capital-raising efforts, interest income on undeployed corporate investments, interest income received on surplus notes with RGA Reinsurance, RCM and Rockwood Re and dividends from operating subsidiaries. As the Company continues its expansion efforts, RGA will continue to be dependent upon these sources of liquidity. The following tables provide comparative information for RGA (dollars in thousands):
 
 
Three months ended March 31,
 
 
2019
 
2018
Interest expense
 
$
48,450

 
$
45,444

Capital contributions to subsidiaries
 
20,500

 
11,000

Dividends to shareholders
 
37,707

 
32,241

Interest and dividend income
 
30,112

 
31,547

 
 
March 31, 2019
 
December 31, 2018
Cash and invested assets
 
$
492,969

 
$
658,850

See Item 15, Schedule II - “Condensed Financial Information of the Registrant” in the 2018 Annual Report for additional financial information related to RGA.
The undistributed earnings of substantially all of the Company’s foreign subsidiaries have been reinvested indefinitely in those non-U.S. operations, as described in Note 9 - “Income Tax” of the Notes to Consolidated Financial Statements in the 2018 Annual Report. As U.S. Tax Reform generally eliminates U.S. federal income taxes on dividends from foreign subsidiaries, the Company does not expect to incur material income taxes if these funds are repatriated.
RGA endeavors to maintain a capital structure that provides financial and operational flexibility to its subsidiaries, credit ratings that support its competitive position in the financial services marketplace, and shareholder returns. As part of the Company’s capital deployment strategy, it has in recent years repurchased shares of RGA common stock and paid dividends to RGA

54

Table of Contents


shareholders, as authorized by the board of directors. RGA’s current share repurchase program, which was approved by the board of directors in January 2019, authorizes the repurchase of up to $400.0 million of common stock. The pace of repurchase activity depends on various factors such as the level of available cash, an evaluation of the costs and benefits associated with alternative uses of excess capital, such as acquisitions and in force reinsurance transactions, and RGA’s stock price.
Details underlying dividend and share repurchase program activity were as follows (in thousands, except share data):
 
Three months ended March 31,
 
2019
 
2018
Dividends to shareholders
$
37,707

 
$
32,241

Repurchases of treasury stock
50,000

 

Total amount paid to shareholders
$
87,707

 
$
32,241

 
 
 
 
Number of shares repurchased
344,237

 

Average price per share
$
145.25

 
$

In April 2019, RGA’s board of directors declared a quarterly dividend of $0.60 per share. All future payments of dividends are at the discretion of RGA’s board of directors and will depend on the Company’s earnings, capital requirements, insurance regulatory conditions, operating conditions, and other such factors as the board of directors may deem relevant. The amount of dividends that RGA can pay will depend in part on the operations of its reinsurance subsidiaries. See Note 3 - “Equity” in the Notes to Condensed Consolidated Financial Statements for information on the Company’s share repurchase program.
Debt
Certain of the Company’s debt agreements contain financial covenant restrictions related to, among others, liens, the issuance and disposition of stock of restricted subsidiaries, minimum requirements of consolidated net worth, maximum ratios of debt to capitalization and change of control provisions. The Company is required to maintain a minimum consolidated net worth, as defined in the debt agreements, of $5.3 billion, calculated as of the last day of each fiscal quarter. Also, consolidated indebtedness, calculated as of the last day of each fiscal quarter, cannot exceed 35% of the sum of the Company’s consolidated indebtedness plus adjusted consolidated stockholders’ equity. A material ongoing covenant default could require immediate payment of the amount due, including principal, under the various agreements. Additionally, the Company’s debt agreements contain cross-default covenants, which would make outstanding borrowings immediately payable in the event of a material uncured covenant default under any of the agreements, including, but not limited to, non-payment of indebtedness when due for an amount in excess of the amounts set forth in those agreements, bankruptcy proceedings, or any other event that results in the acceleration of the maturity of indebtedness.
As of March 31, 2019 and December 31, 2018, the Company had $2.8 billion in outstanding borrowings under its debt agreements and was in compliance with all covenants under those agreements. As of March 31, 2019 and December 31, 2018, the average interest rate on long-term debt outstanding was 5.24%. The ability of the Company to make debt principal and interest payments depends on the earnings and surplus of subsidiaries, investment earnings on undeployed capital proceeds, available liquidity at the holding company, and the Company’s ability to raise additional funds.
The Company enters into derivative agreements with counterparties that reference either the Company’s debt rating or its financial strength rating. If either rating is downgraded in the future, it could trigger certain terms in the Company’s derivative agreements, which could negatively affect overall liquidity. For the majority of the Company’s derivative agreements, there is a termination event, at the Company’s option, should the long-term senior debt ratings drop below either BBB+ (S&P) or Baa1 (Moody’s) or the financial strength ratings drop below either A- (S&P) or A3 (Moody’s).
The Company may borrow up to $850.0 million in cash and obtain letters of credit in multiple currencies on its revolving credit facility that matures in August 2023. As of March 31, 2019, the Company had no cash borrowings outstanding and $18.7 million in issued, but undrawn, letters of credit under this facility.
Based on the historic cash flows and the current financial results of the Company, management believes RGA’s cash flows will be sufficient to enable RGA to meet its obligations for at least the next 12 months.
Credit and Committed Facilities
At March 31, 2019, the Company maintained an $850.0 million syndicated revolving credit facility and certain committed letter of credit facilities aggregating $1,258.9 million. See Note 13 - “Debt” in the Notes to Consolidated Financial Statements in the 2018 Annual Report for further information about these facilities.

55

Table of Contents


The Company has obtained bank letters of credit in favor of various affiliated and unaffiliated insurance companies from which the Company assumes business. These letters of credit represent guarantees of performance under the reinsurance agreements and allow ceding companies to take statutory reserve credits. Certain of these letters of credit contain financial covenant restrictions similar to those described in the “Debt” discussion above. At March 31, 2019, there were approximately $102.2 million of outstanding bank letters of credit in favor of third parties. Additionally, in accordance with applicable regulations, the Company utilizes letters of credit to secure statutory reserve credits when it retrocedes business to its affiliated subsidiaries. The Company cedes business to its affiliates to help reduce the amount of regulatory capital required in certain jurisdictions, such as the U.S. and the UK. The Company believes the capital required to support the business in the affiliates reflects more realistic expectations than the original jurisdiction of the business, where capital requirements are often considered to be quite conservative. As of March 31, 2019, $1.5 billion in letters of credit from various banks were outstanding, but undrawn, backing reinsurance between the various subsidiaries of the Company.
Cash Flows
The Company’s principal cash inflows from its reinsurance operations include premiums and deposit funds received from ceding companies. The primary liquidity concerns with respect to these cash flows are early recapture of the reinsurance contract by the ceding company and lapses of annuity products reinsured by the Company. The Company’s principal cash inflows from its invested assets result from investment income and the maturity and sales of invested assets. The primary liquidity concerns with respect to these cash inflows relates to the risk of default by debtors and interest rate volatility. The Company manages these risks very closely. See “Investments” and “Interest Rate Risk” below.
Additional sources of liquidity to meet unexpected cash outflows in excess of operating cash inflows and current cash and equivalents on hand include selling short-term investments or fixed maturity securities and drawing funds under a revolving credit facility, under which the Company had availability of $831.4 million as of March 31, 2019. The Company also has $747.5 million of funds available through collateralized borrowings from the FHLB as of March 31, 2019. As of March 31, 2019, the Company could have borrowed these additional amounts without violating any of its existing debt covenants.
The Company’s principal cash outflows relate to the payment of claims liabilities, interest credited, operating expenses, income taxes, dividends to shareholders, purchases of treasury stock, and principal and interest under debt and other financing obligations. The Company seeks to limit its exposure to loss on any single insured and to recover a portion of benefits paid by ceding reinsurance to other insurance enterprises or reinsurers under excess coverage and coinsurance contracts (See Note 2, “Significant Accounting Policies and Pronouncements” in the Notes to Consolidated Financial Statements in the 2018 Annual Report). The Company performs annual financial reviews of its retrocessionaires to evaluate financial stability and performance. The Company has never experienced a material default in connection with retrocession arrangements, nor has it experienced any difficulty in collecting claims recoverable from retrocessionaires; however, no assurance can be given as to the future performance of such retrocessionaires nor to the recoverability of future claims. The Company’s management believes its current sources of liquidity are adequate to meet its cash requirements for the next 12 months.

56

Table of Contents


Summary of Primary Sources and Uses of Liquidity and Capital
The Company’s primary sources and uses of liquidity and capital are summarized as follows:
 
 
For the three months ended March 31,
 
 
2019
 
2018
 
 
(Dollars in thousands)
Sources:
 
 
 
 
Net cash provided by operating activities
$
340,621

 
$
223,749

 
Exercise of stock options, net
1,755

 
1,163

 
Change in cash collateral for derivative positions and other arrangements

 
19,537

 
Effect of exchange rate changes on cash
7,141

 
21,989

 
Total sources
349,517

 
266,438

 
 
 
 
 
Uses:
 
 
 
 
Net cash (provided by) used in investing activities
(92,721
)
 
(76,550
)
 
Dividends to stockholders
37,707

 
32,241

 
Repayment of collateral finance and securitization notes
29,064

 
27,104

 
Principal payments of long-term debt
690

 
662

 
Purchases of treasury stock
49,052

 
2,616

 
Change in cash collateral for derivative positions and other arrangements
44,628

 

 
Cash used for changes in universal life and other
 
 
 
 
investment type policies and contracts
150,434

 
73,482

 
Total uses
218,854

 
59,555

Net change in cash and cash equivalents
$
130,663

 
$
206,883

Cash Flows from Operations - The principal cash inflows from the Company’s reinsurance activities come from premiums, investment and fee income, annuity considerations and deposit funds. The principal cash outflows relate to the liabilities associated with various life and health insurance, annuity and disability products, operating expenses, income tax payments and interest on outstanding debt obligations. The primary liquidity concern with respect to these cash flows is the risk of shortfalls in premiums and investment income, particularly in periods with abnormally high claims levels.
Cash Flows from Investments - The principal cash inflows from the Company’s investment activities come from repayments of principal on invested assets, proceeds from maturities of invested assets, sales of invested assets and settlements of freestanding derivatives. The principal cash outflows relate to purchases of investments, issuances of policy loans and settlements of freestanding derivatives. The Company typically has a net cash outflow from investing activities because cash inflows from insurance operations are reinvested in accordance with its asset/liability management discipline to fund insurance liabilities. The Company closely monitors and manages these risks through its credit risk management process. The primary liquidity concerns with respect to these cash flows are the risk of default by debtors and market disruption, which could make it difficult for the Company to sell investments.
Financing Cash Flows - The principal cash inflows from the Company’s financing activities come from issuances of RGA debt and equity securities, and deposit funds associated with universal life and other investment type policies and contracts. The principal cash outflows come from repayments of debt, payments of dividends to stockholders, purchases of treasury stock, and withdrawals associated with universal life and other investment type policies and contracts. A primary liquidity concern with respect to these cash flows is the risk of early contractholder and policyholder withdrawal.
Contractual Obligations
There were no material changes in the Company’s contractual obligations from those reported in the 2018 Annual Report.
Asset / Liability Management
The Company actively manages its cash and invested assets using an approach that is intended to balance quality, diversification, asset/liability matching, liquidity and investment return. The goals of the investment process are to optimize after-tax, risk-adjusted investment income and after-tax, risk-adjusted total return while managing the assets and liabilities on a cash flow and duration basis.
The Company has established target asset portfolios for its operating segments, which represent the investment strategies intended to profitably fund its liabilities within acceptable risk parameters. These strategies include objectives and limits for effective duration, yield curve sensitivity and convexity, liquidity, asset sector concentration and credit quality.

57

Table of Contents


The Company’s asset-intensive products are primarily supported by investments in fixed maturity securities reflected on the Company’s balance sheet and under funds withheld arrangements with the ceding company. Investment guidelines are established to structure the investment portfolio based upon the type, duration and behavior of products in the liability portfolio so as to achieve targeted levels of profitability. The Company manages the asset-intensive business to provide a targeted spread between the interest rate earned on investments and the interest rate credited to the underlying interest-sensitive contract liabilities. The Company periodically reviews models projecting different interest rate scenarios and their effect on profitability. Certain of these asset-intensive agreements, primarily in the U.S. and Latin America Financial Solutions operating segment, are generally funded by fixed maturity securities that are withheld by the ceding company.
The Company’s liquidity position (cash and cash equivalents and short-term investments) was $2,139.6 million and $2,032.3 million at March 31, 2019 and December 31, 2018, respectively. Liquidity needs are determined from valuation analyses conducted by operational units and are driven by product portfolios. Periodic evaluations of demand liabilities and short-term liquid assets are designed to adjust specific portfolios, as well as their durations and maturities, in response to anticipated liquidity needs.
See “Securities Borrowing, Lending and Other” in Note 4 - “Investments” in the Notes to Condensed Consolidated Financial Statements for information related to the Company’s securities borrowing, lending and repurchase/reverse repurchase programs. In addition to its security agreements with third parties, certain RGA’s subsidiaries have entered into intercompany securities lending agreements to more efficiently source securities for lending to third parties and to provide for more efficient regulatory capital management.
The Company is a member of the FHLB and holds $83.5 million of FHLB common stock, which is included in other invested assets on the Company’s condensed consolidated balance sheets. The Company has entered into funding agreements with the FHLB under guaranteed investment contracts whereby the Company has issued the funding agreements in exchange for cash and for which the FHLB has been granted a blanket lien on the Company’s commercial and residential mortgage-backed securities and commercial mortgage loans used to collateralize the Company’s obligations under the funding agreements. The Company maintains control over these pledged assets, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. The funding agreements and the related security agreements represented by this blanket lien provide that upon any event of default by the Company, the FHLB’s recovery is limited to the amount of the Company’s liability under the outstanding funding agreements. The amount of the Company’s liability for the funding agreements with the FHLB under guaranteed investment contracts was $1.8 billion and $1.7 billion at March 31, 2019 and December 31, 2018, respectively, which is included in interest sensitive contract liabilities on the Company’s condensed consolidated balance sheets. The advances on these agreements are collateralized primarily by commercial and residential mortgage-backed securities, commercial mortgage loans, and U.S. Treasury and government agency securities. The amount of collateral exceeds the liability and is dependent on the type of assets collateralizing the guaranteed investment contracts.

58

Table of Contents


Investments
Management of Investments
The Company’s investment and derivative strategies involve matching the characteristics of its reinsurance products and other obligations and to seek to closely approximate the interest rate sensitivity of the assets with estimated interest rate sensitivity of the reinsurance liabilities. The Company achieves its income objectives through strategic and tactical asset allocations, security and derivative strategies within an asset/liability management and disciplined risk management framework. Derivative strategies are employed within the Company’s risk management framework to help manage duration, currency, and other risks in assets and/or liabilities and to replicate the credit characteristics of certain assets. For a discussion of the Company’s risk management process see “Market and Credit Risk” in the “Enterprise Risk Management” section below.
The Company’s portfolio management groups work with the Enterprise Risk Management function to develop the investment policies for the assets of the Company’s domestic and international investment portfolios. All investments held by the Company, directly or in a funds withheld at interest reinsurance arrangement, are monitored for conformance with the Company’s stated investment policy limits as well as any limits prescribed by the applicable jurisdiction’s insurance laws and regulations. See Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for additional information regarding the Company’s investments.
Portfolio Composition
The Company had total cash and invested assets of $58.1 billion and $56.1 billion as of March 31, 2019 and December 31, 2018, respectively, as illustrated below (dollars in thousands):
 
 
March 31, 2019
 
% of Total
 
December 31, 2018
 
% of Total
Fixed maturity securities, available-for-sale
 
$
41,738,443

 
71.8
%
 
$
39,992,346

 
71.3
%
Equity securities
 
89,865

 
0.1

 
82,197

 
0.1

Mortgage loans on real estate
 
5,117,545

 
8.8

 
4,966,298

 
8.8

Policy loans
 
1,312,349

 
2.3

 
1,344,980

 
2.4

Funds withheld at interest
 
5,729,838

 
9.9

 
5,761,471

 
10.3

Short-term investments
 
119,215

 
0.2

 
142,598

 
0.3

Other invested assets
 
2,006,870

 
3.4

 
1,915,297

 
3.4

Cash and cash equivalents
 
2,020,396

 
3.5

 
1,889,733

 
3.4

Total cash and invested assets
 
$
58,134,521

 
100.0
%
 
$
56,094,920

 
100.0
%
Investment Yield
The following table presents consolidated average invested assets at amortized cost, net investment income and investment yield, excluding spread related business. Spread related business is primarily associated with contracts on which the Company earns an interest rate spread between assets and liabilities. To varying degrees, fluctuations in the yield on other spread related business is generally subject to corresponding adjustments to the interest credited on the liabilities (dollars in thousands).
 
Three months ended March 31,
 
2019
 
2018
 
  Increase/  
  (Decrease)  
Average invested assets at amortized cost
$
28,096,587

 
$
27,024,934

 
4.0
%
Net investment income
310,229

 
296,473

 
4.6
%
Investment yield (ratio of net investment income to average invested assets)
4.49
%
 
4.46
%
 
3 bps


Fixed Maturity Securities Available-for-Sale
See “Fixed Maturity Securities Available-for-Sale” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables that provide the amortized cost, unrealized gains and losses, estimated fair value of these securities, and the other-than-temporary impairments in AOCI by sector as of March 31, 2019 and December 31, 2018.

59

Table of Contents


The Company holds various types of fixed maturity securities available-for-sale and classifies them as corporate securities (“Corporate”), Canadian and Canadian provincial government securities (“Canadian government”), residential mortgage-backed securities (“RMBS”), asset-backed securities (“ABS”), commercial mortgage-backed securities (“CMBS”), U.S. government and agencies (“U.S. government”), state and political subdivisions, and other foreign government, supranational and foreign government-sponsored enterprises (“Other foreign government”). For both March 31, 2019 and December 31, 2018, approximately 95.6% of the Company’s consolidated investment portfolio of fixed maturity securities were investment grade.
Important factors in the selection of investments include diversification, quality, yield, call protection and total rate of return potential. The relative importance of these factors is determined by market conditions and the underlying reinsurance liability and existing portfolio characteristics. The largest asset class in which fixed maturity securities were invested was corporate securities, which represented approximately 60.1% and 59.9% of total fixed maturity securities as of March 31, 2019 and December 31, 2018, respectively. See “Corporate Fixed Maturity Securities” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables showing the major industry types, which comprise the corporate fixed maturity holdings at March 31, 2019 and December 31, 2018.
As of March 31, 2019, the Company’s investments in Canadian government securities represented 10.2% of the fair value of total fixed maturity securities compared to 9.7% of the fair value of total fixed maturities at December 31, 2018. These assets are primarily high quality, long duration provincial strips, the valuation of which is closely linked to the interest rate curve. These assets are longer in duration and held primarily for asset/liability management to meet Canadian regulatory requirements. See “Fixed Maturity Securities Available-for-Sale” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables showing the various sectors as of March 31, 2019 and December 31, 2018.
The Company references rating agency designations in some of its investments disclosures. These designations are based on the ratings from nationally recognized statistical rating organizations, primarily Moody’s, S&P and Fitch. Structured securities held by the Company’s insurance subsidiaries that maintain the NAIC statutory basis of accounting utilize the NAIC rating methodology. The NAIC assigns designations to publicly traded as well as privately placed securities. The designations assigned by the NAIC range from class 1 to class 6, with designations in classes 1 and 2 generally considered investment grade (BBB or higher rating agency designation). NAIC designations in classes 3 through 6 are generally considered below investment grade (BB or lower rating agency designation).
The quality of the Company’s available-for-sale fixed maturity securities portfolio, as measured at fair value and by the percentage of fixed maturity securities invested in various ratings categories, relative to the entire available-for-sale fixed maturity security portfolio, at March 31, 2019 and December 31, 2018 was as follows (dollars in thousands):
 
 
 
 
 
March 31, 2019
 
December 31, 2018
NAIC
  Designation  
 
Rating Agency
Designation
 
Amortized Cost 
 
Estimated
Fair Value
 
% of Total     
 
Amortized Cost 
 
Estimated
     Fair  Value     
 
% of Total     
1
 
AAA/AA/A
 
$
25,496,994

 
$
27,673,531

 
66.3
%
 
$
24,904,526

 
$
26,180,440

 
65.5
%
2
 
BBB
 
11,872,478

 
12,244,807

 
29.3

 
12,141,601

 
12,023,426

 
30.1

3
 
BB
 
1,318,883

 
1,319,201

 
3.2

 
1,409,235

 
1,371,328

 
3.4

4
 
B
 
419,764

 
422,390

 
1.0

 
395,694

 
385,670

 
1.0

5
 
CCC and lower
 
13,414

 
14,357

 

 
13,183

 
12,860

 

6
 
In or near default
 
67,094

 
64,157

 
0.2

 
17,929

 
18,622

 

 
 
Total
 
$
39,188,627

 
$
41,738,443

 
100.0
%
 
$
38,882,168

 
$
39,992,346

 
100.0
%

The Company’s fixed maturity portfolio includes structured securities. The following table shows the types of structured securities the Company held at March 31, 2019 and December 31, 2018 (dollars in thousands): 
 
 
March 31, 2019
 
December 31, 2018
 
 
Amortized Cost
 
Estimated
Fair Value
 
Amortized Cost
 
Estimated
Fair Value
RMBS:
 
 
 
 
 
 
 
 
Agency
 
$
798,669

 
$
815,317

 
$
811,044

 
$
814,568

Non-agency
 
1,171,025

 
1,178,869

 
1,061,192

 
1,054,653

Total RMBS
 
1,969,694

 
1,994,186

 
1,872,236

 
1,869,221

CMBS
 
1,404,852

 
1,431,746

 
1,428,115

 
1,419,034

ABS
 
2,243,449

 
2,241,986

 
2,171,254

 
2,149,204

Total
 
$
5,617,995

 
$
5,667,918

 
$
5,471,605

 
$
5,437,459


60

Table of Contents


The Company’s RMBS include agency-issued pass-through securities and collateralized mortgage obligations. A majority of the agency-issued pass-through securities are guaranteed or otherwise supported by the Federal Home Loan Mortgage Corporation, Federal National Mortgage Association, or the Government National Mortgage Association. The principal risks inherent in holding mortgage-backed securities are prepayment and extension risks, which will affect the timing of when cash will be received and are dependent on the level of mortgage interest rates. Prepayment risk is the unexpected increase in principal payments from the expected, primarily as a result of owner refinancing. Extension risk relates to the unexpected slowdown in principal payments from the expected. In addition, non-agency mortgage-backed securities face credit risk should the borrower be unable to pay the contractual interest or principal on their obligation. The Company monitors its mortgage-backed securities to mitigate exposure to the cash flow uncertainties associated with these risks.
The Company’s ABS include credit card receivables, railcar leasing, student loans, single-family rentals, home equity loans and collateralized debt obligations (primarily collateralized loan obligations). The Company owns floating rate securities that represent approximately 16.4% and 16.0% of the total fixed maturity securities at March 31, 2019 and December 31, 2018, respectively. These investments have a higher degree of income variability than the other fixed income holdings in the portfolio due to the floating rate nature of the interest payments. The Company holds these investments to match specific floating rate liabilities primarily reflected in the condensed consolidated balance sheets as collateral finance notes, as well as to enhance asset management strategies. In addition to the risks associated with floating rate securities, principal risks in holding asset-backed securities are structural, credit and capital market risks. Structural risks include the securities’ cash flow priority in the capital structure and the inherent prepayment sensitivity of the underlying collateral. Credit risks include the adequacy and ability to realize proceeds from the collateral. Credit risks are mitigated by credit enhancements that include excess spread, over-collateralization and subordination. Capital market risks include general level of interest rates and the liquidity for these securities in the marketplace.
The Company monitors its fixed maturity securities to determine impairments in value and evaluates factors such as financial condition of the issuer, payment performance, the length of time and the extent to which the market value has been below amortized cost, compliance with covenants, general market and industry sector conditions, current intent and ability to hold securities, and various other subjective factors. Based on management’s judgment, securities determined to have an other-than-temporary impairment in value are written down to fair value. See “Investments – Other-than-Temporary Impairment” in Note 2 – “Significant Accounting Policies and Pronouncements” in the Notes to Consolidated Financial Statements in the 2018 Annual Report for additional information. The table below summarizes other-than-temporary impairments and changes in the mortgage loan provision for the three months ended March 31, 2019 and 2018 (dollars in thousands).
 
Three months ended March 31,
2019
 
2018
Impairment losses on fixed maturity securities
$
9,453

 
$

Other impairment losses
1,932

 
828

Change in mortgage loan provision
(73
)
 
(516
)
Total
$
11,312

 
$
312

The fixed maturity impairments for the three months ended March 31, 2019 were largely related to a U.S. utility company. There were no fixed maturity impairments for the three months ended March 31, 2018. In addition, other impairment losses for the three months ended March 31, 2019 and 2018 were primarily due to impairments on real estate joint ventures.


61

Table of Contents


At March 31, 2019 and December 31, 2018, the Company had $230.2 million and $748.5 million, respectively, of gross unrealized losses related to its fixed maturity securities. The distribution of the gross unrealized losses related to these securities is shown below.
 
 
March 31, 2019
 
December 31, 2018
Sector:
 
 
 
 
Corporate
 
71.3
%
 
74.2
%
Canadian government
 
0.3

 
0.3

RMBS
 
4.5

 
3.4

ABS
 
6.8

 
4.4

CMBS
 
1.4

 
2.4

U.S. government
 
9.2

 
7.7

State and political subdivisions
 
1.1

 
1.2

Other foreign government
 
5.4

 
6.4

Total
 
100.0
%
 
100.0
%
Industry:
 
 
 
 
Finance
 
21.5
%
 
27.5
%
Asset-backed
 
6.8

 
4.4

Industrial
 
43.2

 
38.2

Mortgage-backed
 
5.9

 
5.8

Government
 
16.0

 
15.6

Utility
 
6.6

 
8.5

Total
 
100.0
%
 
100.0
%
See “Unrealized Losses for Fixed Maturity Securities Available-for-Sale” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for a table that presents the total gross unrealized losses for these securities at March 31, 2019 and December 31, 2018, respectively, where the estimated fair value had declined and remained below amortized cost by less than 20% or more than 20%.
The Company’s determination of whether a decline in value is other-than-temporary includes analysis of the underlying credit and the extent and duration of a decline in value. The Company’s credit analysis of an investment includes determining whether the issuer is current on its contractual payments, evaluating whether it is probable that the Company will be able to collect all amounts due according to the contractual terms of the security and analyzing the overall ability of the Company to recover the amortized cost of the investment. In the Company’s impairment review process, the duration and severity of an unrealized loss position for equity securities are given greater weight and consideration given the lack of contractual cash flows and the deferability features of these securities.
See “Unrealized Losses for Fixed Maturity Securities Available-for-Sale” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables that present the estimated fair values and gross unrealized losses, including other-than-temporary impairment losses reported in AOCI, for these securities that have estimated fair values below amortized cost, by class and grade security, as well as the length of time the related market value has remained below amortized cost as of March 31, 2019 and December 31, 2018.
As of March 31, 2019 and December 31, 2018, the Company classified approximately 5.5% and 5.0%, respectively, of its fixed maturity securities in the Level 3 category (refer to Note 6 – “Fair Value of Assets and Liabilities” in the Notes to Condensed Consolidated Financial Statements for additional information). These securities primarily consist of private placement corporate securities, bank loans, and Canadian provincial strips with inactive trading markets.
See “Securities Borrowing, Lending and Other” in Note 4 - “Investments” in the Notes to Condensed Consolidated Financial Statements for information related to the Company’s securities borrowing, lending, repurchase and repurchase/reverse repurchase programs.

62

Table of Contents


Mortgage Loans on Real Estate
Mortgage loans represented approximately 8.8% of the Company’s cash and invested assets as of both March 31, 2019 and December 31, 2018. The Company’s mortgage loan portfolio consists of U.S., Canada and United Kingdom based investments primarily in commercial offices, light industrial properties and retail locations. The mortgage loan portfolio is diversified by geographic region and property type. The mortgage loan portfolio was diversified by geographic region and property type discussed further under “Mortgage Loans on Real Estate” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements.
As of March 31, 2019 and December 31, 2018, the Company’s mortgage loans, gross of unamortized deferred loan origination fees and expenses and valuation allowances, were distributed geographically as follows (dollars in thousands):
 
 
March 31, 2019
 
December 31, 2018
 
 
Recorded
Investment
 
% of Total
 
Recorded
Investment
 
% of Total
U.S. Region:
 
 
 
 
 
 
 
 
Pacific
 
$
1,372,810

 
26.8
%
 
$
1,396,346

 
28.0
%
South Atlantic
 
965,962

 
18.8

 
964,174

 
19.3

Mountain
 
724,392

 
14.1

 
693,281

 
13.9

East North Central
 
620,124

 
12.1

 
605,608

 
12.2

West North Central
 
298,669

 
5.8

 
288,949

 
5.8

West South Central
 
631,742

 
12.3

 
567,541

 
11.4

Middle Atlantic
 
201,250

 
3.9

 
202,235

 
4.1

East South Central
 
139,314

 
2.7

 
117,588

 
2.4

New England
 
5,582

 
0.1

 
5,609

 
0.1

Subtotal - U.S.
 
4,959,845

 
96.6

 
4,841,331

 
97.2

Canada
 
147,701

 
2.9

 
135,394

 
2.7

United Kingdom
 
27,352

 
0.5

 
6,629

 
0.1

Total
 
$
5,134,898

 
100.0
%
 
$
4,983,354

 
100.0
%
Valuation allowances on mortgage loans are established based upon inherent losses expected by management to be realized in connection with future dispositions or settlement of mortgage loans, including foreclosures. The valuation allowances are established after management considers, among other things, the value of underlying collateral and payment capabilities of debtors. Any subsequent adjustments to the valuation allowances will be treated as investment gains or losses.
See “Mortgage Loans on Real Estate” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for information regarding valuation allowances and impairments.
Policy Loans
Policy loans comprised approximately 2.3% and 2.4% of the Company’s cash and invested assets as of March 31, 2019 and December 31, 2018, respectively, the majority of which are associated with one client. These policy loans present no credit risk because the amount of the loan cannot exceed the obligation due the ceding company upon the death of the insured or surrender of the underlying policy. The provisions of the treaties in force and the underlying policies determine the policy loan interest rates. The Company earns a spread between the interest rate earned on policy loans and the interest rate credited to corresponding liabilities.

63

Table of Contents


Funds Withheld at Interest
Funds withheld at interest comprised approximately 9.9% and 10.3% of the Company’s cash and invested assets as of March 31, 2019 and December 31, 2018, respectively. For reinsurance agreements written on a modified coinsurance basis and certain agreements written on a coinsurance basis, assets equal to the net statutory reserves are withheld and legally owned and managed by the ceding company, and are reflected as funds withheld at interest on the Company’s condensed consolidated balance sheets. In the event of a ceding company’s insolvency, the Company would need to assert a claim on the assets supporting its reserve liabilities. However, the risk of loss to the Company is mitigated by its ability to offset amounts it owes the ceding company for claims or allowances against amounts owed by the ceding company. Interest accrues to the total funds withheld at interest assets at rates defined by the treaty terms. The Company is subject to the investment performance on the withheld assets, although it does not directly control them. These assets are primarily fixed maturity investment securities and pose risks similar to the fixed maturity securities the Company owns. To mitigate this risk, the Company helps set the investment guidelines followed by the ceding company and monitors compliance. Ceding companies with funds withheld at interest had an average financial strength rating of “A” at March 31, 2019 and December 31, 2018. Certain ceding companies maintain segregated portfolios for the benefit of the Company.
Other Invested Assets
Other invested assets include limited partnership interests, joint ventures (other than operating joint ventures), equity release mortgages, derivative contracts, FVO contractholder-directed unit-linked investments, and FHLB common stock. Other invested assets represented approximately 3.4% of the Company’s cash and invested assets for both March 31, 2019 and December 31, 2018. See “Other Invested Assets” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for a table that presents the carrying value of the Company’s other invested assets by type as of March 31, 2019 and December 31, 2018.
The Company utilizes derivative financial instruments to protect the Company against possible changes in the fair value of its investment portfolio as a result of interest rate changes, to hedge liabilities associated with the reinsurance of variable annuities with guaranteed living benefits and to manage the portfolio’s effective yield, maturity and duration. In addition, the Company utilizes derivative financial instruments to reduce the risk associated with fluctuations in foreign currency exchange rates. The Company uses both exchange-traded, centrally cleared, and customized over-the-counter derivative financial instruments.
See Note 5 – “Derivative Instruments” in the Notes to Condensed Consolidated Financial Statements for a table that presents the notional amounts and fair value of investment related derivative instruments held at March 31, 2019 and December 31, 2018.
The Company may be exposed to credit-related losses in the event of non-performance by counterparties to derivative financial instruments. Generally, the credit exposure of the Company’s derivative contracts is limited to the fair value at the reporting date plus or minus any collateral posted or held by the Company. The Company had no credit exposure related to its derivative contracts, excluding futures and mortality swaps, at March 31, 2019 and December 31, 2018, as the net amount of collateral pledged to the Company from counterparties exceeded the fair value of the derivative contracts.
The Company manages its credit risk related to over-the-counter derivatives by entering into transactions with creditworthy counterparties, maintaining collateral arrangements and through the use of master agreements that provide for a single net payment to be made by one counterparty to another at each due date and upon termination. As exchange-traded futures are affected through regulated exchanges, and positions are marked to market on a daily basis, the Company has minimal exposure to credit-related losses in the event of nonperformance by counterparties. See Note 5 – “Derivative Instruments” in the Notes to Condensed Consolidated Financial Statements for more information regarding the Company’s derivative instruments.
The Company holds beneficial interests in equity release mortgages in the UK. Equity release mortgages represent loans provided to individuals 55 years of age and older secured by the borrower’s residence. Equity release mortgages are comparable to a home equity loan by allowing the borrower to utilize the equity in their home as collateral. The amount of the loan is dependent on the appraised value of the home at the time of origination, the borrower's age and interest rate. Unlike a home equity loan, no payment of principal or interest is required until the death of the borrower or sale of the home. Equity release mortgages may also be either fully funded at origination, or the borrower can request periodic funding similar to a line of credit. Equity release mortgages are subject to risks, including market, credit, interest rate, liquidity, operational, reputational and legal risks.
Other invested assets include $595.6 million and $475.9 million of equity release mortgages as of March 31, 2019 and December 31, 2018, respectively. Investment income includes $7.1 million and $3.4 million in interest income earned on equity release mortgages for the three months ended March 31, 2019 and 2018, respectively.
New Accounting Standards
See Note 13 — “New Accounting Standards” in the Notes to Condensed Consolidated Financial Statements.


64

Table of Contents


ITEM 3.  Quantitative and Qualitative Disclosures About Market Risk
Market risk is the risk of fluctuations in the value of financial instruments as a result of absolute or relative changes in interest rates, foreign currency exchange rates, equity prices or commodity prices. To varying degrees, the Company products and services, and the investment activities supporting them, generate exposure to market risk. The market risk incurred, and the Company’s strategies for managing this risk, vary by product.  As of March 31, 2019, there have been no material changes in the Company’s economic exposure to market risk or the Company’s Enterprise Risk Management function from December 31, 2018, a description of which may be found in its Annual Report on Form 10-K, for the year ended December 31, 2018, Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” filed with the Securities and Exchange Commission.
ITEM 4.  Controls and Procedures
The Chief Executive Officer and the Chief Financial Officer have evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as defined in Exchange Act Rule 13a-15(e) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that these disclosure controls and procedures were effective.
There was no change in the Company’s internal control over financial reporting as defined in Exchange Act Rule 13a-15(f) during the quarter ended March 31, 2019, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II - OTHER INFORMATION
ITEM 1.  Legal Proceedings
The Company is subject to litigation in the normal course of its business. The Company currently has no material litigation. A legal reserve is established when the Company is notified of an arbitration demand or litigation or is notified that an arbitration demand or litigation is imminent, it is probable that the Company will incur a loss as a result and the amount of the probable loss is reasonably capable of being estimated.
ITEM 1A.  Risk Factors
There were no material changes from the risk factors disclosed in the 2018 Annual Report.
ITEM 2.  Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
The following table summarizes RGA’s repurchase activity of its common stock during the quarter ended March 31, 2019:
 
 
 
Total Number of Shares
Purchased (1)
 
Average Price Paid per   
Share
 
Total Number of Shares
Purchased as Part of
Publicly Announced Plans
or Programs (1)
 
Maximum Number (or
Approximate Dollar
Value) of Shares that May
Yet Be Purchased Under
the Plan or Program
January 1, 2019 -
January 31, 2019
 
10,001

 
$
142.53

 

 
$
89,579,317

February 1, 2019 -
February 28, 2019
 
3,438

 
$
144.24

 

 
$
89,579,317

March 1, 2019 -
March 31, 2019
 
795

 
$
145.25

 
344,237

 
$
39,579,388

 
(1)
RGA had no repurchases of common stock under its share repurchase program for January and February 2019 and repurchased 344,237 of common stock under its share repurchase program for $50.0 million during March 2019. The Company net settled - issuing 29,098, 10,973 and 2,860 shares from treasury and repurchasing from recipients 10,001, 3,438 and 795 shares in January, February and March 2019, respectively, in settlement of income tax withholding requirements incurred by the recipients of equity incentive awards.
On January 24, 2019, RGA’s board of directors authorized a share repurchase program, with no expiration date, for up to $400.0 million of RGA’s outstanding common stock.

65

Table of Contents


ITEM 6.  Exhibits
See index to exhibits.

66

Table of Contents


INDEX TO EXHIBITS
 
 
 
 
Exhibit
Number
 
Description
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

* Represents a management contract or compensatory plan or arrangement

67

Table of Contents


SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
 
Reinsurance Group of America, Incorporated
 
 
Date: May 3, 2019
 
By: 
/s/ Anna Manning
 
 
 
Anna Manning
 
 
 
President & Chief Executive Officer
 
 
 
(Principal Executive Officer)
 
 
 
 
Date: May 3, 2019
 
By:
/s/ Todd C. Larson
 
 
 
Todd C. Larson
 
 
 
Senior Executive Vice President & Chief Financial Officer
 
 
 
(Principal Financial and Accounting Officer)

68